BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM. Alzheimer's disease. Lancet 2021;397:1577-90. [PMID: 33667416 DOI: 10.1016/S0140-6736(20)32205-4] [Cited by in Crossref: 354] [Cited by in F6Publishing: 411] [Article Influence: 354.0] [Reference Citation Analysis]
Number Citing Articles
1 Mishra S, Van Deursen C, Robert A, Van Der Kant R, Young JE. Advantages and limitations of hiPSC-derived neurons for the study of neurodegeneration. Phenotyping of Human iPSC-derived Neurons 2023. [DOI: 10.1016/b978-0-12-822277-5.00016-x] [Reference Citation Analysis]
2 Hu N, Hu Z, Ondrejcak T, Yu P, Zhang Y, Yang Y, Klyubin I, Kennelly S, Rowan M. Do tau-synaptic long-term depression interactions in the hippocampus play a pivotal role in the progression of Alzheimer’s disease? Neural Regen Res 2023;18:1213. [DOI: 10.4103/1673-5374.360166] [Reference Citation Analysis]
3 Pires G, Ueberheide B, Wisniewski T, Drummond E. Use of Affinity Purification–Mass Spectrometry to Identify Phosphorylated Tau Interactors in Alzheimer’s Disease. Methods in Molecular Biology 2023. [DOI: 10.1007/978-1-0716-2655-9_14] [Reference Citation Analysis]
4 Perry J. Challenges of anticipation of future decisions in dementia and dementia research. HPLS 2022;44:62. [DOI: 10.1007/s40656-022-00541-8] [Reference Citation Analysis]
5 Assunção SS, Sperling RA, Ritchie C, Kerwin DR, Aisen PS, Lansdall C, Atri A, Cummings J. Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease. Alz Res Therapy 2022;14:54. [DOI: 10.1186/s13195-022-00984-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Wang X, Song X, Li P, Sun S, Mao J, Liu S, Wei W. Fluorescence method for monoamine oxidase B detection based on the cage function of glyoxal and phenethylamine on G-rich DNA. Sensors and Actuators B: Chemical 2022;372:132624. [DOI: 10.1016/j.snb.2022.132624] [Reference Citation Analysis]
7 Yamashita K, Miura M, Watanabe S, Ishiki K, Arimatsu Y, Kawahira J, Kubo T, Sasaki K, Arai T, Hagino K, Irino Y, Nagai K, Verbel D, Koyama A, Dhadda S, Niiro H, Iwanaga S, Sato T, Yoshida T, Iwata A. Fully automated and highly specific plasma β-amyloid immunoassays predict β-amyloid status defined by amyloid positron emission tomography with high accuracy. Alz Res Therapy 2022;14:86. [DOI: 10.1186/s13195-022-01029-0] [Reference Citation Analysis]
8 Aerqin Q, Wang Z, Wu K, He X, Dong Q, Yu J. Omics-based biomarkers discovery for Alzheimer's disease. Cell Mol Life Sci 2022;79:585. [DOI: 10.1007/s00018-022-04614-6] [Reference Citation Analysis]
9 Li L, He R, Yan H, Leng Z, Zhu S, Gu Z. Nanotechnology for the diagnosis and treatment of Alzheimer's disease: A bibliometric analysis. Nano Today 2022;47:101654. [DOI: 10.1016/j.nantod.2022.101654] [Reference Citation Analysis]
10 Lissaman R, Lancaster TM, Parker GD, Graham KS, Lawrence AD, Hodgetts CJ. Tract-specific differences in white matter microstructure between young adult APOE ε4 carriers and non-carriers: A replication and extension study. Neuroimage: Reports 2022;2:100126. [DOI: 10.1016/j.ynirp.2022.100126] [Reference Citation Analysis]
11 Infantino R, Boccella S, Scuteri D, Perrone M, Ricciardi F, Vitale R, Bonsale R, Parente A, Allocca I, Virtuoso A, De Luca C, Belardo C, Amodeo P, Gentile V, Cirillo G, Bagetta G, Luongo L, Maione S, Guida F. 2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play. Biomedicine & Pharmacotherapy 2022;156:113844. [DOI: 10.1016/j.biopha.2022.113844] [Reference Citation Analysis]
12 Groot C, Cicognola C, Bali D, Triana-baltzer G, Dage JL, Pontecorvo MJ, Kolb HC, Ossenkoppele R, Janelidze S, Hansson O. Diagnostic and prognostic performance to detect Alzheimer’s disease and clinical progression of a novel assay for plasma p-tau217. Alz Res Therapy 2022;14:67. [DOI: 10.1186/s13195-022-01005-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Nitta Y, Sugie A. Studies of neurodegenerative diseases using Drosophila and the development of novel approaches for their analysis. Fly (Austin) 2022;16:275-98. [PMID: 35765969 DOI: 10.1080/19336934.2022.2087484] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
14 Parasoglou P, Osorio RS, Khegai O, Kovbasyuk Z, Miller M, Ho A, Dehkharghani S, Wisniewski T, Convit A, Mosconi L, Brown R. Phosphorus metabolism in the brain of cognitively normal midlife individuals at risk for Alzheimer's disease. Neuroimage: Reports 2022;2:100121. [DOI: 10.1016/j.ynirp.2022.100121] [Reference Citation Analysis]
15 Wang M, Lin F, Zhang X, Zhang M, Yan T, Wu B, Du Y, He B, Jia Y. Combination of Alpinia Oxyphylla Fructus and Schisandra Chinensis Fructus ameliorates aluminum-induced Alzheimer's disease via reducing BACE1 expression. Journal of Chemical Neuroanatomy 2022;126:102180. [DOI: 10.1016/j.jchemneu.2022.102180] [Reference Citation Analysis]
16 Sanchez-sanchez JL, Giudici KV, Guyonnet S, Delrieu J, Li Y, Bateman RJ, Parini A, Vellas B, de Souto Barreto P, Vellas B, Guyonnet S, Carrié I, Brigitte L, Faisant C, Lala F, Delrieu J, Villars H, Combrouze E, Badufle C, Zueras A, Andrieu S, Cantet C, Morin C, Van Kan GA, Dupuy C, Rolland Y, Caillaud C, Ousset P, Lala F, Willis S, Belleville S, Gilbert B, Fontaine F, Dartigues J, Marcet I, Delva F, Foubert A, Cerda S, Marie-noëlle-cuffi, Costes C, Rouaud O, Manckoundia P, Quipourt V, Marilier S, Franon E, Bories L, Pader M, Basset M, Lapoujade B, Faure V, Tong MLY, Malick-loiseau C, Cazaban-campistron E, Desclaux F, Blatge C, Dantoine T, Laubarie-mouret C, Saulnier I, Clément J, Picat M, Bernard-bourzeix L, Willebois S, Désormais I, Cardinaud N, Bonnefoy M, Livet P, Rebaudet P, Gédéon C, Burdet C, Terracol F, Pesce A, Roth S, Chaillou S, Louchart S, Sudres K, Lebrun N, Barro-belaygues N, Touchon J, Bennys K, Gabelle A, Romano A, Touati L, Marelli C, Pays C, Robert P, Le Duff F, Gervais C, Gonfrier S, Gasnier Y, Bordes S, Begorre D, Carpuat C, Khales K, Lefebvre J, El Idrissi SM, Skolil P, Salles J, Dufouil C, Lehéricy S, Chupin M, Mangin J, Bouhayia A, Allard M, Ricolfi F, Dubois D, Martel MPB, Cotton F, Bonafé A, Chanalet S, Hugon F, Bonneville F, Cognard C, Chollet F, Payoux P, Voisin T, Peiffer S, Hitzel A, Zanca M, Monteil J, Darcourt J, Molinier L, Derumeaux H, Costa N, Perret B, Vinel C, Caspar-bauguil S, Olivier-abbal P, Coley N, for the MAPT/DSA Group. Plasma MCP-1 and changes on cognitive function in community-dwelling older adults. Alz Res Therapy 2022;14:5. [DOI: 10.1186/s13195-021-00940-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Hajjo R, Sabbah DA, Abusara OH, Al Bawab AQ. A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics. Diagnostics 2022;12:2975. [DOI: 10.3390/diagnostics12122975] [Reference Citation Analysis]
18 Niotis K, Akiyoshi K, Carlton C, Isaacson R. Dementia Prevention in Clinical Practice. Semin Neurol 2022. [DOI: 10.1055/s-0042-1759580] [Reference Citation Analysis]
19 Zhang J, Chen Z, Chen H, Deng Y, Li S, Jin L. Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases. Biosensors 2022;12:1074. [DOI: 10.3390/bios12121074] [Reference Citation Analysis]
20 Tan W, Qi L, Hu X, Tan Z. Research progress in traditional Chinese medicine in the treatment of Alzheimer’s disease and related dementias. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.921794] [Reference Citation Analysis]
21 Perus L, Busto GU, Mangin J, Le Bars E, Gabelle A. Effects of preventive interventions on neuroimaging biomarkers in subjects at-risk to develop Alzheimer's disease: A systematic review. Front Aging Neurosci 2022;14. [DOI: 10.3389/fnagi.2022.1014559] [Reference Citation Analysis]
22 Tinauer C, Heber S, Pirpamer L, Damulina A, Schmidt R, Stollberger R, Ropele S, Langkammer C. Interpretable brain disease classification and relevance-guided deep learning. Sci Rep 2022;12:20254. [PMID: 36424437 DOI: 10.1038/s41598-022-24541-7] [Reference Citation Analysis]
23 Chen H, Jin X, Li T, Ye Z. Brain organoids: Establishment and application. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.1029873] [Reference Citation Analysis]
24 He Y, Cong L, Liang S, Ma X, Tian J, Li H, Wu Y. Discovery and validation of Ferroptosis-related molecular patterns and immune characteristics in Alzheimer’s disease. Front Aging Neurosci 2022;14. [DOI: 10.3389/fnagi.2022.1056312] [Reference Citation Analysis]
25 Hu L, Xie X, Zhou G, Wen Q, Song L, Luo B, Deng X, Pan Q, Chen G. HMGCS2-Induced Autophagic Degradation of Tau Involves Ketone Body and ANKRD24. JAD 2022. [DOI: 10.3233/jad-220640] [Reference Citation Analysis]
26 Gomes-copeland KKP, Meireles CG, Gomes JVD, Torres AG, Sinoti SBP, Fonseca-bazzo YM, Magalhães PDO, Fagg CW, Simeoni LA, Silveira D. Hippeastrum stapfianum (Kraenzl.) R.S.Oliveira & Dutilh (Amaryllidaceae) Ethanol Extract Activity on Acetylcholinesterase and PPAR-α/γ Receptors. Plants 2022;11:3179. [DOI: 10.3390/plants11223179] [Reference Citation Analysis]
27 Salasova A, Monti G, Andersen OM, Nykjaer A. Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer’s disease. Mol Neurodegeneration 2022;17:74. [DOI: 10.1186/s13024-022-00576-2] [Reference Citation Analysis]
28 Liao Y, Mai X, Wu X, Hu X, Luo X, Zhang G. Exploring the Inhibition of Quercetin on Acetylcholinesterase by Multispectroscopic and In Silico Approaches and Evaluation of Its Neuroprotective Effects on PC12 Cells. Molecules 2022;27:7971. [DOI: 10.3390/molecules27227971] [Reference Citation Analysis]
29 Sun T, Zeng L, Cai Z, Liu Q, Li Z, Liu R. Comprehensive analysis of dysregulated circular RNAs and construction of a ceRNA network involved in the pathology of Alzheimer’s disease in a 5 × FAD mouse model. Front Aging Neurosci 2022;14. [DOI: 10.3389/fnagi.2022.1020699] [Reference Citation Analysis]
30 Du H, Meng X, Yao Y, Xu J. The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer’s disease. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1033479] [Reference Citation Analysis]
31 Shi R, Sheng C, Jin S, Zhang Q, Zhang S, Zhang L, Ding C, Wang L, Wang L, Han Y, Jiang J. Generative adversarial network constrained multiple loss autoencoder: A deep learning‐based individual atrophy detection for Alzheimer's disease and mild cognitive impairment. Human Brain Mapping 2022. [DOI: 10.1002/hbm.26146] [Reference Citation Analysis]
32 Wang B, Fu C, Wei Y, Xu B, Yang R, Li C, Qiu M, Yin Y, Qin D. Ferroptosis-related biomarkers for Alzheimer’s disease: Identification by bioinformatic analysis in hippocampus. Front Cell Neurosci 2022;16. [DOI: 10.3389/fncel.2022.1023947] [Reference Citation Analysis]
33 Yang S, Wang J, Cheng P, Chen L, Hu J, Zhu G. Ginsenoside Rg1 in neurological diseases: From bench to bedside. Acta Pharmacol Sin 2022. [DOI: 10.1038/s41401-022-01022-1] [Reference Citation Analysis]
34 Cao Y, Yu F, Lyu Y, Lu X. Promising candidates from drug clinical trials: Implications for clinical treatment of Alzheimer's disease in China. Front Neurol 2022;13. [DOI: 10.3389/fneur.2022.1034243] [Reference Citation Analysis]
35 Shao H, Wu W, Wang P, Han T, Zhuang C. Role of Necroptosis in Central Nervous System Diseases. ACS Chem Neurosci 2022. [DOI: 10.1021/acschemneuro.2c00405] [Reference Citation Analysis]
36 Choudhary N, Tewari D, Nabavi SF, Kashani HRK, Lorigooini Z, Filosa R, Khan FB, Masoudian N, Nabavi SM. Plant based food bioactives: A boon or bane for neurological disorders. Critical Reviews in Food Science and Nutrition 2022. [DOI: 10.1080/10408398.2022.2131729] [Reference Citation Analysis]
37 Yang F, Chen L, Yu Y, Xu T, Chen L, Yang W, Wu Q, Han Y. Alzheimer’s disease and epilepsy: An increasingly recognized comorbidity. Front Aging Neurosci 2022;14. [DOI: 10.3389/fnagi.2022.940515] [Reference Citation Analysis]
38 Zhang J, Xiao Y, Li Z, Wei N, Lin L, Li K. Reach-to-grasp kinematics and kinetics with and without visual feedback in early-stage Alzheimer’s disease. J NeuroEngineering Rehabil 2022;19:121. [DOI: 10.1186/s12984-022-01108-1] [Reference Citation Analysis]
39 Song Y, Du Y, An Y, Zheng J, Lu Y. A systematic review and meta-analysis of cognitive and behavioral tests in rodents treated with different doses of D-ribose. Front Aging Neurosci 2022;14. [DOI: 10.3389/fnagi.2022.1036315] [Reference Citation Analysis]
40 Zheng F, Pang Y, Li L, Pang Y, Zhang J, Wang X, Raes G. Applications of nanobodies in brain diseases. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.978513] [Reference Citation Analysis]
41 Zang Y, Zhou X, Pan M, Lu Y, Liu H, Xiong J, Feng L. Certification of visinin-like protein-1 (VILIP-1) certified reference material by amino acid-based and sulfur-based liquid chromatography isotope dilution mass spectrometry. Anal Bioanal Chem 2022. [DOI: 10.1007/s00216-022-04401-z] [Reference Citation Analysis]
42 Merrihew GE, Park J, Plubell D, Searle BC, Keene CD, Larsen EB, Bateman R, Perrin RJ, Chhatwal JP, Farlow MR, Mclean CA, Ghetti B, Newell KL, Frosch MP, Montine TJ, Maccoss MJ. A Peptide-Centric Quantitative Proteomics Dataset for the Phenotypic Assessment of Alzheimer’s Disease.. [DOI: 10.1101/2022.11.04.515203] [Reference Citation Analysis]
43 Li K, Wang Q, Wang L, Huang Y. Cognitive dysfunctions in high myopia: An overview of potential neural morpho-functional mechanisms. Front Neurol 2022;13. [DOI: 10.3389/fneur.2022.1022944] [Reference Citation Analysis]
44 Liang H, Xu H, Zheng H, Li C. Editorial: Herbal medicines in managing stroke and neurodegenerative diseases—Is there evidence based on basic and clinical studies?, volume II. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1059848] [Reference Citation Analysis]
45 Xu T, Liu C, Deng S, Gan L, Zhang Z, Yang G, Tian H, Tang Y. The roles of microglia and astrocytes in myelin phagocytosis in the central nervous system. J Cereb Blood Flow Metab 2022. [DOI: 10.1177/0271678x221137762] [Reference Citation Analysis]
46 Chen X, Jiang S, Wang R, Bao X. Neural Stem Cells in the Treatment of Alzheimer’s Disease: Current Status, Challenges, and Future Prospects. JAD 2022. [DOI: 10.3233/jad-220721] [Reference Citation Analysis]
47 Li Q, Jia C, Wu H, Liao Y, Yang K, Li S, Zhang J, Wang J, Li G, Guan F, Leung E, Yuan Z, Hua Q, Pan R. Nao Tan Qing ameliorates Alzheimer's disease-like pathology by regulating glycolipid metabolism and neuroinflammation: A network pharmacology analysis and biological validation. Pharmacological Research 2022;185:106489. [DOI: 10.1016/j.phrs.2022.106489] [Reference Citation Analysis]
48 Yang L, Nao J. Focus on Alzheimer's disease: the role of fibroblast growth factor 21 and autophagy. Neuroscience 2022. [DOI: 10.1016/j.neuroscience.2022.11.003] [Reference Citation Analysis]
49 Li X, Xu M, Bi R, Tan L, Yao Y, Zhang D. Common and rare variants of EGF increase the genetic risk of Alzheimer's disease as revealed by targeted sequencing of growth factors in Han Chinese. Neurobiology of Aging 2022. [DOI: 10.1016/j.neurobiolaging.2022.10.009] [Reference Citation Analysis]
50 Su Y, Zhou Y, Bennett ML, Li S, Carceles-cordon M, Lu L, Huh S, Jimenez-cyrus D, Kennedy BC, Kessler SK, Viaene AN, Helbig I, Gu X, Kleinman JE, Hyde TM, Weinberger DR, Nauen DW, Song H, Ming G. A single-cell transcriptome atlas of glial diversity in the human hippocampus across the postnatal lifespan. Cell Stem Cell 2022;29:1594-1610.e8. [DOI: 10.1016/j.stem.2022.09.010] [Reference Citation Analysis]
51 Ferrari F, Moretti A, Villa RF. Incretin-based drugs as potential therapy for neurodegenerative diseases: current status and perspectives. Pharmacology & Therapeutics 2022;239:108277. [DOI: 10.1016/j.pharmthera.2022.108277] [Reference Citation Analysis]
52 Xu M, Yang Y, Peng J, Zhang Y, Wu B, He B, Jia Y, Yan T. Effects of Alpinae Oxyphyllae Fructus on microglial polarization in a LPS-induced BV2 cells model of neuroinflammation via TREM2. Journal of Ethnopharmacology 2022. [DOI: 10.1016/j.jep.2022.115914] [Reference Citation Analysis]
53 Meng-zhen S, Ju L, Lan-chun Z, Cai-feng D, Shu-da Y, Hao-fei Y, Wei-yan H. Potential therapeutic use of plant flavonoids in AD and PD. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e11440] [Reference Citation Analysis]
54 Lee GY, Kim O, Kim ER, Lee HJ. Biomechanical forces in the aged brain: Relationship to AD. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.121237] [Reference Citation Analysis]
55 Savelieff MG, Chen KS, Elzinga SE, Feldman EL. Diabetes and dementia: Clinical perspective, innovation, knowledge gaps. Journal of Diabetes and its Complications 2022;36:108333. [DOI: 10.1016/j.jdiacomp.2022.108333] [Reference Citation Analysis]
56 Han Y, Wang B, Gao H, He C, Hua R, Liang C, Zhang S, Wang Y, Xin S, Xu J. Vagus Nerve and Underlying Impact on the Gut Microbiota-Brain Axis in Behavior and Neurodegenerative Diseases. JIR 2022;Volume 15:6213-6230. [DOI: 10.2147/jir.s384949] [Reference Citation Analysis]
57 Loughrey DG. Is age-related hearing loss a potentially modifiable risk factor for dementia? The Lancet Healthy Longevity 2022. [DOI: 10.1016/s2666-7568(22)00252-5] [Reference Citation Analysis]
58 Yang Q, Wang Y, Yang M, Ge S, Cheng S, Wang C, Zhang W, Tian C, Mao J. Apathy co-occurs with subjective cognitive decline among community-dwelling older adults. Geriatric Nursing 2022;48:173-178. [DOI: 10.1016/j.gerinurse.2022.09.018] [Reference Citation Analysis]
59 Ji H, Kang X, Yang X, Chen H, Zhu L, Mao T, He Y, Liu J, Wang Q, Zhou X, Li G, Wu M, Cong H, Wu L, Qin Y. Functionalized graphene-based electrochemical array sensors for the identification of distinct conformational states of Amyloid Beta in Alzheimer's disease. Biosensors and Bioelectronics 2022. [DOI: 10.1016/j.bios.2022.114927] [Reference Citation Analysis]
60 Lin M, Ma C, Zhu J, Gao J, Huang L, Huang J, Liu Z, Tao J, Chen L. Effects of exercise interventions on executive function in old adults with mild cognitive impairment: A systematic review and meta-analysis of randomized controlled trials. Ageing Research Reviews 2022. [DOI: 10.1016/j.arr.2022.101776] [Reference Citation Analysis]
61 Yi X, Marmontel de Souza B, Sawatani T, Szymczak F, Marselli L, Marchetti P, Cnop M, Eizirik DL. Mining the transcriptome of target tissues of autoimmune and degenerative pancreatic β-cell and brain diseases to discover therapies. iScience 2022;25:105376. [DOI: 10.1016/j.isci.2022.105376] [Reference Citation Analysis]
62 Haeger A, Boumezbeur F, Bottlaender M, Rabrait-lerman C, Lagarde J, Mirzazade S, Krahe J, Hohenfeld C, Sarazin M, Schulz JB, Romanzetti S, Reetz K. 3T Sodium MR Imaging in Alzheimer’s Disease Shows Stage-dependent Sodium Increase Influenced by Age and Local Brain Volume. NeuroImage: Clinical 2022. [DOI: 10.1016/j.nicl.2022.103274] [Reference Citation Analysis]
63 Yuan X, Wang H, Zhang F, Zhang M, Wang Q, Wang J. The common genes involved in the pathogenesis of Alzheimer's disease and type 2 diabetes and their implication for drug repositioning. Neuropharmacology 2022. [DOI: 10.1016/j.neuropharm.2022.109327] [Reference Citation Analysis]
64 Guo Y, Wang S, Chao X, Li D, Wang Y, Guo Q, Chen T. Multi-omics studies reveal ameliorating effects of physical exercise on neurodegenerative diseases. Front Aging Neurosci 2022;14. [DOI: 10.3389/fnagi.2022.1026688] [Reference Citation Analysis]
65 Al-nakkash L, Mason D, Ismail N, Bowman T, Ahlert J, Rubin M, Smith E, Rosander A, Broderick TL. Exercise Training Prevents the Loss of Wall Thickness and Lowers Expression of Alzheimer’s Related Proteins in 3xTg Mouse Jejunum. IJERPH 2022;19:14164. [DOI: 10.3390/ijerph192114164] [Reference Citation Analysis]
66 Gao F, Zhang P, Gao J, Song J, Chi S, Alzheimer’s Disease Neuroimaging Initiative. The CCL2 rs4586 SNP Is Associated with Slower Amyloid-β Deposition and Faster Tau Accumulation of Alzheimer’s Disease. JAD 2022. [DOI: 10.3233/jad-220716] [Reference Citation Analysis]
67 Palmioli A, Mazzoni V, De Luigi A, Bruzzone C, Sala G, Colombo L, Bazzini C, Zoia CP, Inserra M, Salmona M, De Noni I, Ferrarese C, Diomede L, Airoldi C. Alzheimer’s Disease Prevention through Natural Compounds: Cell-Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity. ACS Chem Neurosci 2022. [DOI: 10.1021/acschemneuro.2c00444] [Reference Citation Analysis]
68 Koch G, Casula EP, Bonnì S, Borghi I, Assogna M, Minei M, Pellicciari MC, Motta C, D’acunto A, Porrazzini F, Maiella M, Ferrari C, Caltagirone C, Santarnecchi E, Bozzali M, Martorana A. Precuneus magnetic stimulation for Alzheimer’s disease: a randomized, sham-controlled trial. Brain 2022. [DOI: 10.1093/brain/awac285] [Reference Citation Analysis]
69 Blennow K, Stomrud E, Zetterberg H, Borlinghaus N, Corradini V, Manuilova E, Müller-hübner L, Quevenco F, Rutz S, Hansson O. Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease. Clinical Chemistry and Laboratory Medicine (CCLM) 2022;0. [DOI: 10.1515/cclm-2022-0516] [Reference Citation Analysis]
70 Wang J, Buto P, Ackley SF, Kobayashi LC, Graff RE, Zimmerman SC, Asiimwe SB, Calmasini C, Glymour MM. Association between cancer and dementia risk in the UK Biobank: evidence of diagnostic bias.. [DOI: 10.1101/2022.10.20.22281285] [Reference Citation Analysis]
71 Gao S, Hao J, Zhao Y, Li X, Wang T, Han Z, Sun B, Sun J, Liu G. An updated analysis of the association between CD2-associated protein gene rs9349407 polymorphism and Alzheimer’s disease in Chinese population. Front Neuroinform 2022;16:1006164. [DOI: 10.3389/fninf.2022.1006164] [Reference Citation Analysis]
72 Sun D, Xu J, Zhang W, Song C, Gao C, He Y, Shang Y. Negative regulator NLRC3: Its potential role and regulatory mechanism in immune response and immune-related diseases. Front Immunol 2022;13:1012459. [DOI: 10.3389/fimmu.2022.1012459] [Reference Citation Analysis]
73 Wang Y, Wang M, Zeng X, Liu Y, Wang Y, Yu J. Associations of Naturally Occurring Antibodies to Presenilin-1 with Brain Amyloid-β Load and Cognitive Impairment in Alzheimer’s Disease. JAD 2022. [DOI: 10.3233/jad-220775] [Reference Citation Analysis]
74 Huang Z, Li M, Zhang L, Liu Y. Electrochemical immunosensor based on superwettable microdroplet array for detecting multiple Alzheimer’s disease biomarkers. Front Bioeng Biotechnol 2022;10:1029428. [DOI: 10.3389/fbioe.2022.1029428] [Reference Citation Analysis]
75 Ruzha Y, Ni J, Quan Z, Li H, Qing H. Role of Vitronectin and Its Receptors in Neuronal Function and Neurodegenerative Diseases. Int J Mol Sci 2022;23:12387. [PMID: 36293243 DOI: 10.3390/ijms232012387] [Reference Citation Analysis]
76 Liu WY, Li Y, Li Y, Xu LZ, Jia JP. Carnosic Acid Attenuates AβOs-Induced Apoptosis and Synaptic Impairment via Regulating NMDAR2B and Its Downstream Cascades in SH-SY5Y Cells. Mol Neurobiol 2022. [PMID: 36224322 DOI: 10.1007/s12035-022-03032-w] [Reference Citation Analysis]
77 Zhang Y, Ding N, Hao X, Zhao J, Zhao Y, Li Y, Li Z. Manual acupuncture benignly regulates blood-brain barrier disruption and reduces lipopolysaccharide loading and systemic inflammation, possibly by adjusting the gut microbiota. Front Aging Neurosci 2022;14:1018371. [DOI: 10.3389/fnagi.2022.1018371] [Reference Citation Analysis]
78 Xiao X, Liu H, Zhou L, Liu X, Xu T, Zhu Y, Yang Q, Hao X, Liu Y, Zhang W, Zhou Y, Wang J, Li J, Jiao B, Shen L, Liao X. The associations of APP, PSEN1, and PSEN2 genes with Alzheimer's disease: A large case-control study in Chinese population. CNS Neurosci Ther 2022. [PMID: 36217304 DOI: 10.1111/cns.13987] [Reference Citation Analysis]
79 Zou C, Huang X, Zhang Y, Pan M, Xie J, Chen L, Meng Y, Zou D, Luo J. Potential biomarkers of Alzheimer’s disease and cerebral small vessel disease. Front Mol Neurosci 2022;15:996107. [DOI: 10.3389/fnmol.2022.996107] [Reference Citation Analysis]
80 Xiao Z, Wu W, Ma X, Liang X, Lu J, Zheng L, Ding S, Lei Q, Luo J, Chen K, Ding D, Zhao Q. Plasma Aβ42/Aβ40 and p-tau 181 Predict Long-Term Clinical Progression in a Cohort with Amnestic Mild Cognitive Impairment. Clin Chem 2022:hvac149. [PMID: 36208187 DOI: 10.1093/clinchem/hvac149] [Reference Citation Analysis]
81 Li Y, Xia X, Wang Y, Zheng JC. Mitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer's disease. J Neuroinflammation 2022;19:248. [PMID: 36203194 DOI: 10.1186/s12974-022-02613-9] [Reference Citation Analysis]
82 Puvogel S, Alsema A, Kracht L, Webster MJ, Weickert CS, Sommer IEC, Eggen BJL. Single-nucleus RNA sequencing of midbrain blood-brain barrier cells in schizophrenia reveals subtle transcriptional changes with overall preservation of cellular proportions and phenotypes. Mol Psychiatry 2022. [PMID: 36192459 DOI: 10.1038/s41380-022-01796-0] [Reference Citation Analysis]
83 Kerr NR, Booth FW. Contributions of physical inactivity and sedentary behavior to metabolic and endocrine diseases. Trends in Endocrinology & Metabolism 2022. [DOI: 10.1016/j.tem.2022.09.002] [Reference Citation Analysis]
84 Reynolds CF 3rd, Jeste DV, Sachdev PS, Blazer DG. Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry 2022;21:336-63. [PMID: 36073714 DOI: 10.1002/wps.20996] [Reference Citation Analysis]
85 Wang E, Wang N, Zou Y, Fahim M, Zhou Y, Yang H, Liu Y, Li H. Black mulberry (Morus nigra) fruit extract alleviated AD-Like symptoms induced by toxic Aβ protein in transgenic Caenorhabditis elegans via insulin DAF-16 signaling pathway. Food Research International 2022;160:111696. [DOI: 10.1016/j.foodres.2022.111696] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Yi C, Chen K, Liang H, Wang Z, Wang T, Li K, Yu J, Sun J, Jin C. Novel difluoromethylated 1-(phenylsulfonyl)-4-(piperazin-1-yl)-1H-indole derivatives as potent 5-HT6 receptor antagonist with AMDE-improving properties: Design, synthesis, and biological evaluation. Bioorganic & Medicinal Chemistry 2022;71:116950. [DOI: 10.1016/j.bmc.2022.116950] [Reference Citation Analysis]
87 Gorelick PB. Blood and Cerebrospinal Fluid Biomarkers in Vascular Dementia and Alzheimer’s Disease. Clinics in Geriatric Medicine 2022. [DOI: 10.1016/j.cger.2022.08.001] [Reference Citation Analysis]
88 Trenaman SC, von Maltzahn M, Sketris I, Tamim H, Wang Y, Stewart SA. Patterns of Antipsychotic Dispensation to Long-Term Care Residents. Journal of the American Medical Directors Association 2022. [DOI: 10.1016/j.jamda.2022.09.009] [Reference Citation Analysis]
89 Popp J, Georgescu D, Bürge M, Mundwiler-pachlatko E, Bernasconi L, Felbecker A. Biomarker in der Diagnostik kognitiver Störungen – Empfehlungen der Swiss Memory Clinics. Praxis 2022;111:738-744. [DOI: 10.1024/1661-8157/a003913] [Reference Citation Analysis]
90 Zheng Q, Zhou Z, Hou X, Lv N, Zhang Y, Cao H. Transcriptome Analysis of the Mouse Medial Prefrontal Cortex in Chronic Constriction Injury Model: Implications of neuropathic pain-induced cognitive impairment.. [DOI: 10.21203/rs.3.rs-2108118/v1] [Reference Citation Analysis]
91 Chojdak-łukasiewicz J, Bizoń A, Waliszewska-prosół M, Piwowar A, Budrewicz S, Pokryszko-dragan A. Role of Sirtuins in Physiology and Diseases of the Central Nervous System. Biomedicines 2022;10:2434. [DOI: 10.3390/biomedicines10102434] [Reference Citation Analysis]
92 Perl YS, Fittipaldi S, González Campo C, Moguilner S, Cruzat J, Herzog R, Kringelbach M, Deco G, Prado P, Ibañez A, Tagliazucchi E. Model-based whole-brain perturbational landscape of neurodegenerative diseases.. [DOI: 10.1101/2022.09.26.509612] [Reference Citation Analysis]
93 Palmer WC, Park SM, Levendovszky SR. Brain state transition analysis using ultra-fast fMRI differentiates MCI from cognitively normal controls. Front Neurosci 2022;16:975305. [DOI: 10.3389/fnins.2022.975305] [Reference Citation Analysis]
94 Li R, Deng M, Lin Y, Gao W, Liu B, Xia H. Genetically predicted circulating levels of glycine, glutamate, and serotonin in relation to the risks of three major neurodegenerative diseases: A Mendelian randomization analysis. Front Aging Neurosci 2022;14:938408. [PMID: 36158554 DOI: 10.3389/fnagi.2022.938408] [Reference Citation Analysis]
95 Wu X, Peng C, Nelson PT, Cheng Q. Machine Learning Approach Predicts Probability of Time to Stage-Specific Conversion of Alzheimer’s Disease. JAD 2022. [DOI: 10.3233/jad-220590] [Reference Citation Analysis]
96 Wang X, He Z. Lentiviral Vectors for Gene Therapy. eLS 2022. [DOI: 10.1002/9780470015902.a0029449] [Reference Citation Analysis]
97 Shen W, Elahi M, Wang B, Zhan M, Yang P, Yang P. Oxidative Stress Kinase Activation and Impaired Insulin Receptor Signaling Precede Overt Alzheimer’s Disease Neuropathology. JAD 2022. [DOI: 10.3233/jad-215687] [Reference Citation Analysis]
98 Zhang H, Fang H, Liu D, Zhang Y, Adu-amankwaah J, Yuan J, Tan R, Zhu J. Applications and challenges of rhodopsin-based optogenetics in biomedicine. Front Neurosci 2022;16:966772. [DOI: 10.3389/fnins.2022.966772] [Reference Citation Analysis]
99 Picone P, Sanfilippo T, Vasto S, Baldassano S, Guggino R, Nuzzo D, Bulone D, San Biagio PL, Muscolino E, Monastero R, Dispenza C, Giacomazza D. From Small Peptides to Large Proteins against Alzheimer’sDisease. Biomolecules 2022;12:1344. [DOI: 10.3390/biom12101344] [Reference Citation Analysis]
100 Liu R, Ren Y, Hou T, Liang X, Dong Y, Wang Y, Cong L, Wang X, Qin Y, Ren J, Sindi S, Tang S, Du Y, Qiu C. Associations of sleep timing and time in bed with dementia and cognitive decline among Chinese older adults: A cohort study. J Am Geriatr Soc 2022. [PMID: 36128778 DOI: 10.1111/jgs.18042] [Reference Citation Analysis]
101 Zhu G, Guo M, Zhao J, Zhang H, Wang G, Chen W. Bifidobacterium breve intervention combined with environmental enrichment alleviates cognitive impairment by regulating the gut microbiota and microbial metabolites in Alzheimer’s disease mice. Front Immunol 2022;13:1013664. [DOI: 10.3389/fimmu.2022.1013664] [Reference Citation Analysis]
102 Song J, Jia Y, Han H, Yang X, Zhang J, Zhang M, Liu J, Zhang Q, Wang S, Wang C, Chen L, Zhang M. Expression of SLC25A18 is positively correlated with Alzheimer's disease.. [DOI: 10.21203/rs.3.rs-1955488/v1] [Reference Citation Analysis]
103 Tang Z, Guo M, Peng Y, Zhang T, Xiao Y, Ni R, Qi X. Quercetin reduces APP expression, oxidative stress and mitochondrial dysfunction in the N2a/APPswe cells via ERK1/2 and AKT pathways.. [DOI: 10.1101/2022.09.18.508406] [Reference Citation Analysis]
104 Wu L, Cao T, Li S, Yuan Y, Zhang W, Huang L, Cai C, Fan L, Li L, Wang J, Liu T, Wang J. Long-term gamma transcranial alternating current stimulation improves the memory function of mice with Alzheimer’s disease. Front Aging Neurosci 2022;14:980636. [DOI: 10.3389/fnagi.2022.980636] [Reference Citation Analysis]
105 Li M, Cheng W, Zhang L, Zhou C, Peng X, Yu S, Zhang W. Novel Roles of RNA m6A Methylation Regulators in the Occurrence of Alzheimer’s Disease and the Subtype Classification. IJMS 2022;23:10766. [DOI: 10.3390/ijms231810766] [Reference Citation Analysis]
106 Rajput A, Pingale P, Dhapte-pawar V. Nasal delivery of neurotherapeutics via nanocarriers: Facets, aspects, and prospects. Front Pharmacol 2022;13:979682. [DOI: 10.3389/fphar.2022.979682] [Reference Citation Analysis]
107 Qian X, Liu X, Chen S, Tang H. Integrating peripheral blood and brain transcriptomics to identify immunological features associated with Alzheimer’s disease in mild cognitive impairment patients. Front Immunol 2022;13:986346. [DOI: 10.3389/fimmu.2022.986346] [Reference Citation Analysis]
108 Siew JJ, Chern Y, Khoo KH, Angata T. Roles of Siglecs in neurodegenerative diseases. Mol Aspects Med 2022;:101141. [PMID: 36089405 DOI: 10.1016/j.mam.2022.101141] [Reference Citation Analysis]
109 Huang Y, Deng Y, Zhang P, Lin J, Guo D, Yang L, Liu D, Xu B, Huang C, Zhang H. Associations of fish oil supplementation with incident dementia: Evidence from the UK Biobank cohort study. Front Neurosci 2022;16:910977. [DOI: 10.3389/fnins.2022.910977] [Reference Citation Analysis]
110 Wang P, Yu L, Gong J, Xiong J, Zi S, Xie H, Zhang F, Mao Z, Liu Z, Kim JS. An Activity‐Based Fluorescent Probe for Imaging Fluctuations of Peroxynitrite (ONOO ) in the Alzheimer's Disease Brain. Angew Chem Int Ed 2022;61. [DOI: 10.1002/anie.202206894] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
111 Merone M, D'Addario SL, Mirino P, Bertino F, Guariglia C, Ventura R, Capirchio A, Baldassarre G, Silvetti M, Caligiore D. A multi-expert ensemble system for predicting Alzheimer transition using clinical features. Brain Inform 2022;9:20. [PMID: 36056985 DOI: 10.1186/s40708-022-00168-2] [Reference Citation Analysis]
112 Watson CM, Dammer EB, Ping L, Duong DM, Modeste E, Carter EK, Johnson ECB, Levey AI, Lah JJ, Roberts BR, Seyfried NT. Quantitative Mass Spectrometry Analysis of Cerebrospinal Fluid Biomarker Proteins Reveals Stage-Specific Changes in Alzheimer’s Disease.. [DOI: 10.1101/2022.08.30.22279370] [Reference Citation Analysis]
113 Andersen OM, Bøgh N, Landau AM, Pløen GG, Jensen AMG, Monti G, Ulhøi BP, Nyengaard JR, Jacobsen KR, Jørgensen MM, Holm IE, Kristensen ML, Alstrup AKO, Hansen ES, Teunissen CE, Breidenbach L, Droescher M, Liu Y, Pedersen HS, Callesen H, Luo Y, Bolund L, Brooks DJ, Laustsen C, Small SA, Mikkelsen LF, Sørensen CB. A genetically modified minipig model for Alzheimer’s disease with SORL1 haploinsufficiency. Cell Reports Medicine 2022;3:100740. [DOI: 10.1016/j.xcrm.2022.100740] [Reference Citation Analysis]
114 Di Benedetto G, Burgaletto C, Bellanca CM, Munafò A, Bernardini R, Cantarella G. Role of Microglia and Astrocytes in Alzheimer’s Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation. Cells 2022;11:2728. [DOI: 10.3390/cells11172728] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
115 Long Y, Li D, Yu S, Shi A, Deng J, Wen J, Li XQ, Ma Y, Zhang YL, Liu SY, Wan JY, Li N, Yang M, Han L. Medicine-food herb: Angelica sinensis, a potential therapeutic hope for Alzheimer's disease and related complications. Food Funct 2022;13:8783-803. [PMID: 35983893 DOI: 10.1039/d2fo01287a] [Reference Citation Analysis]
116 Ohno K, Abdelhamid M, Zhou C, Jung C, Michikawa M. Bifidobacterium breve MCC1274 Supplementation Increased the Plasma Levels of Metabolites with Potential Anti-Oxidative Activity in APP Knock-In Mice. JAD 2022. [DOI: 10.3233/jad-220479] [Reference Citation Analysis]
117 Zhang Y, Guo K, Zhang P, Zhang M, Li X, Zhou S, Sun H, Wang W, Wang H, Hu Y. Exploring the mechanism of YangXue QingNao Wan based on network pharmacology in the treatment of Alzheimer’s disease. Front Genet 2022;13:942203. [DOI: 10.3389/fgene.2022.942203] [Reference Citation Analysis]
118 Clemons GA, Silva ACE, Acosta CH, Udo MSB, Tesic V, Rodgers KM, Wu CY, Citadin CT, Lee RH, Neumann JT, Allani S, Prentice H, Zhang Q, Lin HW. Protein arginine methyltransferase 4 modulates nitric oxide synthase uncoupling and cerebral blood flow in Alzheimer's disease. J Cell Physiol 2022. [PMID: 36036549 DOI: 10.1002/jcp.30858] [Reference Citation Analysis]
119 Zheng B, Gao A, Huang X, Li Y, Liang D, Long X. A modified 3D EfficientNet for the classification of Alzheimer's disease using structural magnetic resonance images. IET Image Processing. [DOI: 10.1049/ipr2.12618] [Reference Citation Analysis]
120 Chen C, Liu JW, Guo LL, Xiong F, Ran XQ, Guo YR, Yao YG, Hao XJ, Luo RC, Zhang Y. Monoterpenoid indole alkaloid dimers from Kopsia arborea inhibit cyclin-dependent kinase 5 and tau phosphorylation. Phytochemistry 2022;:113392. [PMID: 36030903 DOI: 10.1016/j.phytochem.2022.113392] [Reference Citation Analysis]
121 Tian M, Zuo C, Civelek AC, Carrio I, Watanabe Y, Kang KW, Murakami K, Garibotto V, Prior JO, Barthel H, Guan Y, Lu J, Zhou R, Jin C, Wu S, Zhang X, Zhong Y, Zhang H, Molecular Imaging-Based Precision Medicine Task Group of A3 (China-Japan-Korea) Foresight Program. International Nuclear Medicine Consensus on the Clinical Use of Amyloid Positron Emission Tomography in Alzheimer’s Disease. Phenomics 2022. [DOI: 10.1007/s43657-022-00068-9] [Reference Citation Analysis]
122 Shi B, Zhao J, Xu Z, Chen C, Xu L, Xu C, Sun M, Kuang H. Chiral Nanoparticles Force Neural Stem Cell Differentiation to Alleviate Alzheimer's Disease. Adv Sci (Weinh) 2022;:e2202475. [PMID: 36008133 DOI: 10.1002/advs.202202475] [Reference Citation Analysis]
123 Zhu Y, Liu Y, Escames G, Yang Z, Zhao H, Qian L, Xue C, Xu D, Acuña-Castroviejo D, Yang Y. Deciphering clock genes as emerging targets against aging. Ageing Res Rev 2022;:101725. [PMID: 36029999 DOI: 10.1016/j.arr.2022.101725] [Reference Citation Analysis]
124 Xiao X, Xu T, Liu H, Liu X, Liao X, Zhou Y, Zhou L, Wang X, Zhu Y, Yang Q, Hao X, Liu Y, Jiang H, Guo J, Wang J, Tang B, Li J, Shen L, Jiao B. CYLD variants identified in Alzheimer's disease and frontotemporal dementia patients. Ann Clin Transl Neurol 2022. [PMID: 36000313 DOI: 10.1002/acn3.51655] [Reference Citation Analysis]
125 Kumar V, Kim S, Bishayee K. Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential Pharmacological Interventions. IJMS 2022;23:9540. [DOI: 10.3390/ijms23179540] [Reference Citation Analysis]
126 He Y, Cong L, He Q, Feng N, Wu Y. Development and validation of immune-based biomarkers and deep learning models for Alzheimer’s disease. Front Genet 2022;13:968598. [DOI: 10.3389/fgene.2022.968598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Li HL, Zhang SY, Ren YS, Zhou JC, Zhou YX, Huang WZ, Piao XH, Yang ZY, Wang SM, Ge YW. Identification of ellagic acid and urolithins as natural inhibitors of Aβ25-35-induced neurotoxicity and the mechanism predication using network pharmacology analysis and molecular docking. Front Nutr 2022;9:966276. [PMID: 35983489 DOI: 10.3389/fnut.2022.966276] [Reference Citation Analysis]
128 Wei Z, Zeng K, Hu J, Li X, Huang F, Zhang B, Wang J, Liu R, Li H, Wang X. USP10 deubiquitinates Tau, mediating its aggregation. Cell Death Dis 2022;13:726. [DOI: 10.1038/s41419-022-05170-4] [Reference Citation Analysis]
129 Hampel H, Au R, Mattke S, van der Flier WM, Aisen P, Apostolova L, Chen C, Cho M, De Santi S, Gao P, Iwata A, Kurzman R, Saykin AJ, Teipel S, Vellas B, Vergallo A, Wang H, Cummings J. Designing the next-generation clinical care pathway for Alzheimer’s disease. Nat Aging 2022;2:692-703. [DOI: 10.1038/s43587-022-00269-x] [Reference Citation Analysis]
130 Wu J, Liu Y, Song Y, Wang L, Ai J, Li K. Aging conundrum: A perspective for ovarian aging. Front Endocrinol 2022;13:952471. [DOI: 10.3389/fendo.2022.952471] [Reference Citation Analysis]
131 Morató X, Pytel V, Jofresa S, Ruiz A, Boada M. Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer’s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach. IJMS 2022;23:9305. [DOI: 10.3390/ijms23169305] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
132 Li S. Advances in Research and Treatment on Patients with Alzheimer's disease Induced by Sleep disorders. HSET 2022;8:396-405. [DOI: 10.54097/hset.v8i.1184] [Reference Citation Analysis]
133 Zhang Y, Niu C. Relation of CDC42, Th1, Th2, and Th17 cells with cognitive function decline in Alzheimer's disease. Ann Clin Transl Neurol 2022. [PMID: 35976992 DOI: 10.1002/acn3.51643] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
134 Malik N, Amber S, Zahid S. Rosmarinus officinalis and Methylphenidate Exposure Improves Cognition and Depression and Regulates Anxiety-Like Behavior in AlCl3-Induced Mouse Model of Alzheimer’s Disease. Front Pharmacol 2022;13:943163. [DOI: 10.3389/fphar.2022.943163] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
135 Mckenzie C, Bucks RS, Weinborn M, Bourgeat P, Salvado O, Gavett BE. Residual reserve index modifies the effect of amyloid pathology on fluorodeoxyglucose metabolism: Implications for efficiency and capacity in cognitive reserve. Front Aging Neurosci 2022;14:943823. [DOI: 10.3389/fnagi.2022.943823] [Reference Citation Analysis]
136 Sun E, Motolani A, Campos L, Lu T. The Pivotal Role of NF-kB in the Pathogenesis and Therapeutics of Alzheimer’s Disease. IJMS 2022;23:8972. [DOI: 10.3390/ijms23168972] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
137 Chen Q, Wang T, Kang D, Chen L. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis. Sci Rep 2022;12:13620. [PMID: 35948759 DOI: 10.1038/s41598-022-18033-x] [Reference Citation Analysis]
138 Terao I, Honyashiki M, Inoue T. Comparative efficacy of lithium and aducanumab for cognitive decline in patients with mild cognitive impairment or Alzheimer's disease: A systematic review and network meta-analysis. Ageing Res Rev 2022;81:101709. [PMID: 35961514 DOI: 10.1016/j.arr.2022.101709] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
139 Wang L, Feng Q, Ge X, Chen F, Yu B, Chen B, Liao Z, Lin B, Lv Y, Ding Z. Textural features reflecting local activity of the hippocampus improve the diagnosis of Alzheimer’s disease and amnestic mild cognitive impairment: A radiomics study based on functional magnetic resonance imaging. Front Neurosci 2022;16:970245. [DOI: 10.3389/fnins.2022.970245] [Reference Citation Analysis]
140 He Q, Shi L, Luo Y, Wan C, Malone IB, Mok VCT, Cole JH, Anatürk M. Validation of the Alzheimer’s disease-resemblance atrophy index in classifying and predicting progression in Alzheimer’s disease. Front Aging Neurosci 2022;14:932125. [DOI: 10.3389/fnagi.2022.932125] [Reference Citation Analysis]
141 Wu Q, Xu X, Zhai C, Zhao Z, Dai W, Wang T, Shen Y. High-frequency repetitive transcranial magnetic stimulation improves spatial episodic learning and memory performance by regulating brain plasticity in healthy rats. Front Neurosci 2022;16:974940. [DOI: 10.3389/fnins.2022.974940] [Reference Citation Analysis]
142 Young JE, Jayadev S. Neighborhood matters: Altered lipid metabolism in APOE4 microglia causes problems for neurons. Cell Stem Cell 2022;29:1159-60. [PMID: 35931027 DOI: 10.1016/j.stem.2022.07.001] [Reference Citation Analysis]
143 Mahmoud Z, Sayed HS, Mohamed LW, Mohamed KO. Development of new donepezil analogs: synthesis, biological screening and in silico study rational. Med Chem Res. [DOI: 10.1007/s00044-022-02941-8] [Reference Citation Analysis]
144 Roe CM. Improving Our Understanding of Driving Changes in Preclinical and Early Symptomatic Alzheimer’s Disease: The Role of Naturalistic Driving Studies. ADR 2022. [DOI: 10.3233/adr-220024] [Reference Citation Analysis]
145 Liang L, Yan J, Huang X, Zou C, Chen L, Li R, Xie J, Pan M, Zou D, Liu Y. Identification of molecular signatures associated with sleep disorder and Alzheimer’s disease. Front Psychiatry 2022;13:925012. [DOI: 10.3389/fpsyt.2022.925012] [Reference Citation Analysis]
146 Li W, Jiang J, Zou X, Zhang Y, Sun M, Jia Z, Li W, Xu J. The characteristics of arterial spin labeling cerebral blood flow in patients with subjective cognitive decline: The Chinese imaging, biomarkers, and lifestyle study. Front Neurosci 2022;16:961164. [DOI: 10.3389/fnins.2022.961164] [Reference Citation Analysis]
147 Mishra S, Knupp A, Kinoshita C, Martinez R, Theofilas P, Young JE. Pharmacologic Stabilization of Retromer Rescues Endosomal Pathology Induced by Defects in the Alzheimer’s gene SORL1.. [DOI: 10.1101/2022.07.31.502217] [Reference Citation Analysis]
148 Lin C, Xu C, Zhou Y, Chen A, Jin B. Identification of Biomarkers Related to M2 Macrophage Infiltration in Alzheimer’s Disease. Cells 2022;11:2365. [DOI: 10.3390/cells11152365] [Reference Citation Analysis]
149 Imbimbo BP, Ippati S, Imbimbo C, Balducci C. Should we lower or raise levels of amyloid-β in the brains of Alzheimer patients? Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106390] [Reference Citation Analysis]
150 Shimada Y, Sato Y, Kumazoe M, Kitamura R, Fujimura Y, Tachibana H. Myricetin improves cognitive function in SAMP8 mice and upregulates brain-derived neurotrophic factor and nerve growth factor. Biochemical and Biophysical Research Communications 2022;616:33-40. [DOI: 10.1016/j.bbrc.2022.05.039] [Reference Citation Analysis]
151 Chen S, Zhang W, Li Y, Yang L, Huang Y, Deng Y, Wu B, Suckling J, Rolls ET, Feng J, Cheng W, Dong Q, Yu J. A phenome-wide association and Mendelian randomization study for Alzheimer’ disease: a prospective cohort study of 502,493 participants from UK Biobank. Biological Psychiatry 2022. [DOI: 10.1016/j.biopsych.2022.08.002] [Reference Citation Analysis]
152 Tong J, Zhang J, Xu L, Liu M, Min J, Yao M, Cheng X, Zhang Q, Sun X, Yuan J. Effect of hearing loss on cognitive function in patients with mild cognitive impairment: A prospective, randomized, and controlled study. Front Aging Neurosci 2022;14:934921. [DOI: 10.3389/fnagi.2022.934921] [Reference Citation Analysis]
153 Tampi RR, Jeste DV. Dementia Is More Than Memory Loss: Neuropsychiatric Symptoms of Dementia and Their Nonpharmacological and Pharmacological Management. Am J Psychiatry 2022;179:528-43. [PMID: 35921394 DOI: 10.1176/appi.ajp.20220508] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
154 Athanasiou E, Gargalionis AN, Anastassopoulou C, Tsakris A, Boufidou F. New Insights into the Molecular Interplay between Human Herpesviruses and Alzheimer’s Disease—A Narrative Review. Brain Sciences 2022;12:1010. [DOI: 10.3390/brainsci12081010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Tian Y, Lu Y, Cao Y, Dang C, Wang N, Tian K, Luo Q, Guo E, Luo S, Wang L, Li Q. Identification of diagnostic signatures associated with immune infiltration in Alzheimer’s disease by integrating bioinformatic analysis and machine-learning strategies. Front Aging Neurosci 2022;14:919614. [DOI: 10.3389/fnagi.2022.919614] [Reference Citation Analysis]
156 Zhao Y, Liu B, Wang J, Xu L, Yu S, Fu J, Yan X, Su J. Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer’s Disease. Biomedicines 2022;10:1800. [DOI: 10.3390/biomedicines10081800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
157 Martínez-Drudis L, Sheta R, Pellegrinato R, Loukili S, Tremblay C, Calon F, Rivest S, Oueslati A. Inhibition of PLK2 activity affects APP and tau pathology and improves synaptic content in a sex-dependent manner in a 3xTg mouse model of Alzheimer's disease. Neurobiol Dis 2022;172:105833. [PMID: 35905928 DOI: 10.1016/j.nbd.2022.105833] [Reference Citation Analysis]
158 Li RX, Ma YH, Tan L, Yu JT. Prospective Biomarkers of Alzheimer's Disease: A Systematic Review and Meta-analysis. Ageing Res Rev 2022;:101699. [PMID: 35905816 DOI: 10.1016/j.arr.2022.101699] [Reference Citation Analysis]
159 Kumari A, Rahaman A, Zeng X, Farooq MA, Huang Y, Yao R, Ali M, Ishrat R, Ali R. Temporal Cortex Microarray Analysis Revealed Impaired Ribosomal Biogenesis and Hyperactivity of the Glutamatergic System: An Early Signature of Asymptomatic Alzheimer's Disease. Front Neurosci 2022;16:966877. [DOI: 10.3389/fnins.2022.966877] [Reference Citation Analysis]
160 Liu Y, Liu X, Li M, Liu Q, Xu T. Portable Vertical Graphene@Au-Based Electrochemical Aptasensing Platform for Point-of-Care Testing of Tau Protein in the Blood. Biosensors 2022;12:564. [DOI: 10.3390/bios12080564] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
161 Zhang X, Lin L, Li H, Xia W, Liu Q, Zhou X, Dong L, Fu X. Update on new trend and progress of the mechanism of polysaccharides in the intervention of Alzheimer's disease, based on the new understanding of relevant theories: A review. Int J Biol Macromol 2022;218:720-38. [PMID: 35902016 DOI: 10.1016/j.ijbiomac.2022.07.158] [Reference Citation Analysis]
162 Tan LF, Chan YH, Merchant RA. Association between dentition and frailty and cognitive function in community-dwelling older adults. BMC Geriatr 2022;22:614. [PMID: 35879659 DOI: 10.1186/s12877-022-03305-y] [Reference Citation Analysis]
163 Çinar R. Depletion of glutathione induced apoptosis and oxidative stress via the activation of TRPM2 channels in the microglia cells with Alzheimer’ disease model. J Cell Neurosci Oxid Stress 2022;14:1063-1073. [DOI: 10.37212/jcnos.1147935] [Reference Citation Analysis]
164 Li J, Zou B, Cheng X, Yang X, Li J, Zhao C, Ma R, Tian J, Yao Y. Therapeutic effects of total saikosaponins from Radix bupleuri against Alzheimer’s disease. Front Pharmacol 2022;13:940999. [DOI: 10.3389/fphar.2022.940999] [Reference Citation Analysis]
165 Wang H, Devadoss D, Nair M, Chand HS, Lakshmana MK. Novel Alzheimer risk factor IQ motif containing protein K is abundantly expressed in the brain and is markedly increased in patients with Alzheimer’s disease. Front Cell Neurosci 2022;16:954071. [DOI: 10.3389/fncel.2022.954071] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
166 Chuluunbat M, Matsuda D, Fujita K, Otomo M, Otomi Y, Kudo K, Harada M, Izumi Y. Identification and validation of a gray matter volume network in Alzheimer's disease. J Neurol Sci 2022;440:120344. [PMID: 35908305 DOI: 10.1016/j.jns.2022.120344] [Reference Citation Analysis]
167 Li Y, Huang X, Fowler C, Lim YY, Laws SM, Faux N, Doecke JD, Trounson B, Pertile K, Rumble R, Doré V, Villemagne VL, Rowe CC, Wiley JS, Maruff P, Masters CL, Gu BJ. Identification of Leukocyte Surface P2X7 as a Biomarker Associated with Alzheimer's Disease. Int J Mol Sci 2022;23:7867. [PMID: 35887215 DOI: 10.3390/ijms23147867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
168 Li Q, Zhang S, Wang X, Du M, Zhang Q. Risk factors and a nomogram for frailty in Chinese older patients with Alzheimer's disease: A single-center cross-sectional study. Geriatr Nurs 2022;47:47-54. [PMID: 35850031 DOI: 10.1016/j.gerinurse.2022.06.012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
169 Torres-Flores M, Peña-Ortega F. Amyloid Beta Alters Prefrontal-dependent Functions Along with its Excitability and Synaptic Plasticity in Male Rats. Neuroscience 2022:S0306-4522(22)00349-9. [PMID: 35839923 DOI: 10.1016/j.neuroscience.2022.07.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
170 Chen H, Yu C, Liu W, Zhu C, Jiang X, Xu C, Liu W, Huang Y, Xu Z, Zhao Q. Discovery of novel α-carboline derivatives as glycogen synthase kinase-3β inhibitors for the treatment of Alzheimer's disease. Arch Pharm (Weinheim) 2022;:e2200156. [PMID: 35836098 DOI: 10.1002/ardp.202200156] [Reference Citation Analysis]
171 Yang L, Cui Y, Liang H, Li Z, Wang N, Wang Y, Zheng G. Multifunctional Selenium Nanoparticles with Different Surface Modifications Ameliorate Neuroinflammation through the Gut Microbiota-NLRP3 Inflammasome-Brain Axis in APP/PS1 Mice. ACS Appl Mater Interfaces 2022;14:30557-70. [PMID: 35758423 DOI: 10.1021/acsami.2c06283] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
172 Wei J, Ma X, Nehme A, Cui Y, Zhang L, Qiu S. Reduced HGF/MET Signaling May Contribute to the Synaptic Pathology in an Alzheimer's Disease Mouse Model. Front Aging Neurosci 2022;14:954266. [DOI: 10.3389/fnagi.2022.954266] [Reference Citation Analysis]
173 Zhan Y, Fu Q, Pei J, Fan M, Yu Q, Guo M, Zhou H, Wang T, Wang L, Chen Y. Modulation of Brain Activity and Functional Connectivity by Acupuncture Combined With Donepezil on Mild-to-Moderate Alzheimer's Disease: A Neuroimaging Pilot Study. Front Neurol 2022;13:912923. [DOI: 10.3389/fneur.2022.912923] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
174 Sang Z, Bai P, Ban Y, Wang K, Wu A, Mi J, Hu J, Xu R, Zhu G, Wang J, Zhang J, Wang C, Tan Z, Tang L. Novel donepezil-chalcone-rivastigmine hybrids as potential multifunctional anti-Alzheimer's agents: Design, synthesis, in vitro biological evaluation, in vivo and in silico studies. Bioorg Chem 2022;127:106007. [PMID: 35849893 DOI: 10.1016/j.bioorg.2022.106007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
175 Lopez-font I, Lennol MP, Iborra-lazaro G, Zetterberg H, Blennow K, Sáez-valero J. Altered Balance of Reelin Proteolytic Fragments in the Cerebrospinal Fluid of Alzheimer’s Disease Patients. IJMS 2022;23:7522. [DOI: 10.3390/ijms23147522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Wang Y, Zhang H, Liu D, Li X, Long L, Peng Y, Qi F, Wang Y, Jiang W, Wang Z. Discovery of carbamate-based N-salicyloyl tryptamine derivatives as novel pleiotropic agents for the treatment of Alzheimer's disease. Bioorg Chem 2022;127:105993. [PMID: 35834980 DOI: 10.1016/j.bioorg.2022.105993] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
177 Yi C, Xue Y, Chen K, Wang T, Yu J, Wang Z, Jin C. Novel Difluoromethyl-Containing 1-((4-methoxy-3-(piperazin-1-yl)phenyl)sulfonyl)-1H-indole Scaffold as Potent 5-HT6R Antagonists: Design, Synthesis, Biological Evaluation, and Early in vivo Cognition-Enhancing Studies. Bioorganic & Medicinal Chemistry 2022. [DOI: 10.1016/j.bmc.2022.116917] [Reference Citation Analysis]
178 de Eguileor M, Grimaldi A, Pulze L, Acquati F, Morsiani C, Capri M. Amyloid fil rouge from invertebrate up to human ageing: a focus on Alzheimer Disease. Mechanisms of Ageing and Development 2022. [DOI: 10.1016/j.mad.2022.111705] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
179 Zhang J, Ma S, Liu X, Du Y, Zhu X, Liu Y, Wu X. Activating transcription factor 6 regulates cystathionine to increase autophagy and restore memory in Alzheimer’ s disease model mice. Biochemical and Biophysical Research Communications 2022;615:109-15. [DOI: 10.1016/j.bbrc.2022.05.053] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
180 Onur OA, Wolff-Menzler C, von Arnim CAF, Jessen F, Fink GR, Wiltfang J, Laske C, Schneider A, Levin J, Oberstein T, Kornhuber J, Oberhauser F, Gallinat J, Dodel R, Otto M, Peters O, Teipel S, Duezel E, Riemenschneider M, Flöel A, Perneczky R, Reetz K, Schulz JB, Hausner L, Grimmer T, Frölich L. [The Cost of Early Diagnosis of Cognitive Decline in German Memory Clinics]. Fortschr Neurol Psychiatr 2022;90:361-7. [PMID: 35858613 DOI: 10.1055/a-1871-9889] [Reference Citation Analysis]
181 Thu Thuy Nguyen V, Endres K. Targeting gut microbiota to alleviate neuroinflammation in Alzheimer's disease. Adv Drug Deliv Rev 2022;:114418. [PMID: 35787390 DOI: 10.1016/j.addr.2022.114418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
182 van Olst L, Coenen L, Nieuwland JM, Rodriguez-Mogeda C, de Wit NM, Kamermans A, Middeldorp J, de Vries HE. Crossing borders in Alzheimer's disease: A T cell's perspective. Adv Drug Deliv Rev 2022;188:114398. [PMID: 35780907 DOI: 10.1016/j.addr.2022.114398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
183 Sawicka-Gutaj N, Zawalna N, Gut P, Ruchała M. Relationship between thyroid hormones and central nervous system metabolism in physiological and pathological conditions. Pharmacol Rep 2022. [PMID: 35771431 DOI: 10.1007/s43440-022-00377-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Sun D, Peng H, Wu Z. Establishment and Analysis of a Combined Diagnostic Model of Alzheimer's Disease With Random Forest and Artificial Neural Network. Front Aging Neurosci 2022;14:921906. [DOI: 10.3389/fnagi.2022.921906] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
185 Wang S, Kong X, Chen Z, Wang G, Zhang J, Wang J. Role of Natural Compounds and Target Enzymes in the Treatment of Alzheimer’s Disease. Molecules 2022;27:4175. [DOI: 10.3390/molecules27134175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Barnes C. A Study on Psychometric Assessment Data for Autonomous Dementia Detection. The15th International Conference on PErvasive Technologies Related to Assistive Environments 2022. [DOI: 10.1145/3529190.3534726] [Reference Citation Analysis]
187 Wang Y, Wang L, Yuan S, Zhang Y, Zhang X, Zhou L. Postoperative Cognitive Dysfunction and Alzheimer’s Disease: A Transcriptome-Based Comparison of Animal Models. Front Aging Neurosci 2022;14:900350. [DOI: 10.3389/fnagi.2022.900350] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
188 Yu WS, Aquili L, Wong KH, Lo ACY, Chan LLH, Chan YS, Lim LW. Transcorneal electrical stimulation enhances cognitive functions in aged and 5XFAD mouse models. Ann N Y Acad Sci 2022. [PMID: 35751874 DOI: 10.1111/nyas.14850] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
189 Zhou QM, Zhao HY, Ma C, Huang L, Liu J, Guo L, Peng C, Xiong L. Pocahemiketone A, a Sesquiterpenoid Possessing a Spirocyclic Skeleton with a Hemiketal Endoperoxide Unit, Alleviates Aβ25-35-Induced Pyroptosis and Oxidative Stress in SH-SY5Y Cells. Org Lett 2022. [PMID: 35749446 DOI: 10.1021/acs.orglett.2c01587] [Reference Citation Analysis]
190 Bianchin MM, Snow Z. Primary microglia dysfunction or microgliopathy: A cause of dementias and other neurological or psychiatric disorders. Neuroscience 2022:S0306-4522(22)00333-5. [PMID: 35760218 DOI: 10.1016/j.neuroscience.2022.06.032] [Reference Citation Analysis]
191 Li X, Zhang P, Li H, Yu H, Xi Y. The Protective Effects of Zeaxanthin on Amyloid-β Peptide 1–42-Induced Impairment of Learning and Memory Ability in Rats. Front Behav Neurosci 2022;16:912896. [DOI: 10.3389/fnbeh.2022.912896] [Reference Citation Analysis]
192 Tsirkou A, Kaczorowski F, Verdurand M, Raffoul R, Pansieri J, Quadrio I, Chauveau F, Antoine R. Charge detection mass spectrometry on human-amplified fibrils from different synucleinopathies. Chem Commun (Camb) 2022;58:7192-5. [PMID: 35670578 DOI: 10.1039/d2cc00200k] [Reference Citation Analysis]
193 Li X, Lu Y, Zhang S, Sai N, Fan Y, Cheng Y, Liu Q. Mechanism of Neural Regeneration Induced by Natural Product LY01 in the 5×FAD Mouse Model of Alzheimer’s Disease. Front Pharmacol 2022;13:926123. [DOI: 10.3389/fphar.2022.926123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Ye X, Wang H, Cheng S, Xia L, Xu X, Li X. Network Pharmacology-Based Strategy to Investigate the Pharmacologic Mechanisms of Coptidis Rhizoma for the Treatment of Alzheimer's Disease. Front Aging Neurosci 2022;14:890046. [DOI: 10.3389/fnagi.2022.890046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
195 Pan R, Luo S, Huang Q, Li W, Cai T, Lai K, Shi X; Alzheimer’s Disease Neuroimaging Initiative. The Associations of Cerebrospinal Fluid Ferritin with Neurodegeneration and Neuroinflammation Along the Alzheimer's Disease Continuum. J Alzheimers Dis 2022. [PMID: 35754266 DOI: 10.3233/JAD-220002] [Reference Citation Analysis]
196 Kang N, Luan Y, Jiang Y, Cheng W, Liu Y, Su Z, Liu Y, Tan P. Neuroprotective Effects of Oligosaccharides in Rehmanniae Radix on Transgenic Caenorhabditis elegans Models for Alzheimer’s Disease. Front Pharmacol 2022;13:878631. [DOI: 10.3389/fphar.2022.878631] [Reference Citation Analysis]
197 Hurst C, Pugh DA, Abreha MH, Duong DM, Dammer EB, Bennett DA, Herskowitz JH, Seyfried NT. Integrated Proteomics Identifies Neuritin (NRN1) as a Mediator of Cognitive Resilience to Alzheimer’s Disease.. [DOI: 10.1101/2022.06.15.496285] [Reference Citation Analysis]
198 Zapata-Acevedo JF, García-Pérez V, Cabezas-Pérez R, Losada-Barragán M, Vargas-Sánchez K, González-Reyes RE. Laminin as a Biomarker of Blood-Brain Barrier Disruption under Neuroinflammation: A Systematic Review. Int J Mol Sci 2022;23:6788. [PMID: 35743229 DOI: 10.3390/ijms23126788] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
199 Colca JR, Finck BN. Metabolic Mechanisms Connecting Alzheimer’s and Parkinson’s Diseases: Potential Avenues for Novel Therapeutic Approaches. Front Mol Biosci 2022;9:929328. [DOI: 10.3389/fmolb.2022.929328] [Reference Citation Analysis]
200 Therriault J, Zimmer ER, Benedet AL, Pascoal TA, Gauthier S, Rosa-Neto P. Staging of Alzheimer's disease: past, present, and future perspectives. Trends Mol Med 2022:S1471-4914(22)00137-X. [PMID: 35717526 DOI: 10.1016/j.molmed.2022.05.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
201 Makmee P, Wongupparaj P. Virtual Reality-based Cognitive Intervention for Enhancing Executive Functions in Community-dwelling Older Adults. Psychosocial Intervention 2022. [DOI: 10.5093/pi2022a10] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
202 Li Q, Peng J, Luo Y, Zhou J, Li T, Cao L, Peng S, Zuo Z, Wang Z. Far infrared light irradiation enhances Aβ clearance via increased exocytotic microglial ATP and ameliorates cognitive deficit in Alzheimer's disease-like mice. J Neuroinflammation 2022;19:145. [PMID: 35701825 DOI: 10.1186/s12974-022-02521-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
203 Littau JL, Velilla L, Hase Y, Villalba-Moreno ND, Hagel C, Drexler D, Osorio Restrepo S, Villegas A, Lopera F, Vargas S, Glatzel M, Krasemann S, Quiroz YT, Arboleda-Velasquez JF, Kalaria R, Sepulveda-Falla D. Evidence of beta amyloid independent small vessel disease in familial Alzheimer's disease. Brain Pathol 2022;:e13097. [PMID: 35695802 DOI: 10.1111/bpa.13097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 Zhou B, Dou X, Wang W, Yao H, Feng F, Wang P, Yang Z, An N, Liu B, Zhang X, Liu Y. Structural and functional connectivity abnormalities of the default mode network in patients with Alzheimer's disease and mild cognitive impairment within two independent datasets. Methods 2022;205:29-38. [PMID: 35671900 DOI: 10.1016/j.ymeth.2022.06.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
205 Hannonen S, Andberg S, Kärkkäinen V, Rusanen M, Lehtola JM, Saari T, Korhonen V, Hokkanen L, Hallikainen M, Hänninen T, Leinonen V, Kaarniranta K, Bednarik R, Koivisto AM. Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer's Disease. J Alzheimers Dis 2022. [PMID: 35662117 DOI: 10.3233/JAD-215551] [Reference Citation Analysis]
206 Tian Z, Ji X, Liu J. Neuroinflammation in Vascular Cognitive Impairment and Dementia: Current Evidence, Advances, and Prospects. Int J Mol Sci 2022;23:6224. [PMID: 35682903 DOI: 10.3390/ijms23116224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
207 Yang Z, Wang J, Chen J, Luo M, Xie Q, Rong Y, Wu Y, Cao Z, Liu Y. High-resolution NMR metabolomics of patients with subjective cognitive decline plus: Perturbations in the metabolism of glucose and branched-chain amino acids. Neurobiology of Disease 2022. [DOI: 10.1016/j.nbd.2022.105782] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
208 Wang ZB, Wang ZT, Sun Y, Tan L, Yu JT. The future of stem cell therapies of Alzheimer's disease. Ageing Res Rev 2022;:101655. [PMID: 35660003 DOI: 10.1016/j.arr.2022.101655] [Reference Citation Analysis]
209 Wang X, Li B, Yu X, Zhou Y, Gao Y. The Neuroprotective Effect of GM-1 Ganglioside on the Amyloid-Beta-Induced Oxidative Stress in PC-12 Cells Mediated by Nrf-2/ARE Signaling Pathway. Neurochem Res. [DOI: 10.1007/s11064-022-03635-8] [Reference Citation Analysis]
210 Gutiérrez IL, Dello Russo C, Novellino F, Caso JR, García-Bueno B, Leza JC, Madrigal JLM. Noradrenaline in Alzheimer's Disease: A New Potential Therapeutic Target. Int J Mol Sci 2022;23:6143. [PMID: 35682822 DOI: 10.3390/ijms23116143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
211 Chen B, Marquez-nostra B, Belitzky E, Toyonaga T, Tong J, Huang Y, Cai Z. PET Imaging in Animal Models of Alzheimer’s Disease. Front Neurosci 2022;16:872509. [DOI: 10.3389/fnins.2022.872509] [Reference Citation Analysis]
212 Liu P, Jiang C. Brain-targeting drug delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2022;:e1818. [PMID: 35596258 DOI: 10.1002/wnan.1818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
213 Zhang K, Ma X, Zhang R, Liu Z, Jiang L, Qin Y, Zhang D, Tian P, Gao Z, Zhang N, Shi Z, Xu S. Crosstalk Between Gut Microflora and Vitamin D Receptor SNPs Are Associated with the Risk of Amnestic Mild Cognitive Impairment in a Chinese Elderly Population. JAD 2022. [DOI: 10.3233/jad-220101] [Reference Citation Analysis]
214 Bao J, Liu J, Li Z, Zhang Z, Su X, Sun J, Tu J, Wang J, Li J, Song Y, Ning X. Relationship Between Hypertension and Cognitive Function in an Elderly Population: A Population-Based Study in Rural Northern China. Front Neurol 2022;13:885598. [DOI: 10.3389/fneur.2022.885598] [Reference Citation Analysis]
215 Roddick KM, Fertan E, Schellinck HM, Brown RE. A Signal Detection Analysis of Olfactory Learning in 12-Month-Old 5xFAD Mice. JAD 2022. [DOI: 10.3233/jad-220049] [Reference Citation Analysis]
216 Jian J, Fan D, Tian D, Cheng Y, Sun P, Tan C, Zeng G, He C, Wang Y, Zhu J, Yao X, Wang Y, Liu Y. Naturally-Occurring Antibodies Against Bim are Decreased in Alzheimer’s Disease and Attenuate AD-type Pathology in a Mouse Model. Neurosci Bull . [DOI: 10.1007/s12264-022-00869-y] [Reference Citation Analysis]
217 Hu X, Liu C, Wang K, Zhao L, Qiu Y, Chen H, Hu J, Xu J. Multifunctional Anti-Alzheimer’s Disease Effects of Natural Xanthone Derivatives: A Primary Structure-Activity Evaluation. Front Chem 2022;10:842208. [DOI: 10.3389/fchem.2022.842208] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
218 Blessing EM, Parekh A, Betensky RA, Babb J, Saba N, Debure L, Varga AW, Ayappa I, Rapoport DM, Butler TA, de Leon MJ, Wisniewski T, Lopresti BJ, Osorio RS. Association between lower body temperature and increased tau pathology in cognitively normal older adults. Neurobiol Dis 2022;171:105748. [PMID: 35550158 DOI: 10.1016/j.nbd.2022.105748] [Reference Citation Analysis]
219 Cummings J, Lee G, Nahed P, Kambar MEZN, Zhong K, Fonseca J, Taghva K. Alzheimer's disease drug development pipeline: 2022. Alzheimers Dement (N Y) 2022;8:e12295. [PMID: 35516416 DOI: 10.1002/trc2.12295] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 12.0] [Reference Citation Analysis]
220 Kverno K. New Treatment Aimed at Preventing Alzheimer's Dementia. J Psychosoc Nurs Ment Health Serv 2022;60:11-4. [PMID: 35510912 DOI: 10.3928/02793695-20220324-02] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
221 Song W, Feng Y, Gong Z, Tian C. The Association Between Dietary Inflammatory Index and Cognitive Performance in Older Adults Aged 60 Years and Older. Front Nutr 2022;9:748000. [PMID: 35495906 DOI: 10.3389/fnut.2022.748000] [Reference Citation Analysis]
222 Chakrabarty R, Yousuf S, Singh MP. Contributive Role of Hyperglycemia and Hypoglycemia Towards the Development of Alzheimer's Disease. Mol Neurobiol 2022. [PMID: 35503159 DOI: 10.1007/s12035-022-02846-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
223 Li Y, Zheng J, Li T, Zhang J. White Matter and Alzheimer's Disease: A Bidirectional Mendelian Randomization Study. Neurol Ther 2022. [PMID: 35501561 DOI: 10.1007/s40120-022-00353-9] [Reference Citation Analysis]
224 Ogata K, Moriyama M, Matsumura-kawashima M, Kawado T, Yano A, Nakamura S. The Therapeutic Potential of Secreted Factors from Dental Pulp Stem Cells for Various Diseases. Biomedicines 2022;10:1049. [DOI: 10.3390/biomedicines10051049] [Reference Citation Analysis]
225 Tan Y, Wang X, Zhang J, Zhang H, Li H, Peng T, Chen W, Wei P, Liu Z, He F, Li J, Ding H, Li N, Wang Z, Zhang Z, Hua Q. NeuroProtect, a Candidate Formula From Traditional Chinese Medicine, Attenuates Amyloid-β and Restores Synaptic Structures in APP/PS1 Transgenic Mice. Front Pharmacol 2022;13:850175. [PMID: 35586051 DOI: 10.3389/fphar.2022.850175] [Reference Citation Analysis]
226 Ossenkoppele R, van der Kant R, Hansson O. Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials. The Lancet Neurology 2022. [DOI: 10.1016/s1474-4422(22)00168-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
227 Rai M, Curley M, Coleman Z, Demontis F. Contribution of proteases to the hallmarks of aging and to age-related neurodegeneration. Aging Cell 2022;21:e13603. [PMID: 35349763 DOI: 10.1111/acel.13603] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
228 Scuto M, Modafferi S, Rampulla F, Zimbone V, Tomasello M, Spano’ S, Ontario M, Palmeri A, Trovato Salinaro A, Siracusa R, Di Paola R, Cuzzocrea S, Calabrese E, Wenzel U, Calabrese V. Redox modulation of stress resilience by Crocus Sativus L. for potential neuroprotective and anti-neuroinflammatory applications in brain disorders: From molecular basis to therapy. Mechanisms of Ageing and Development 2022. [DOI: 10.1016/j.mad.2022.111686] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
229 Zhou Y, Hua J, Ding D, Tang Y. Interrogating amyloid aggregation with aggregation-induced emission fluorescence probes. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
230 Studart-neto A, Coutinho AM. From clinical phenotype to proteinopathy: molecular neuroimaging in neurodegenerative dementias. Arq Neuro-Psiquiatr 2022;80:24-35. [DOI: 10.1590/0004-282x-anp-2022-s138] [Reference Citation Analysis]
231 Li S, Zhou Q, Liu E, Du H, Yu N, Yu H, Wang W, Li M, Weng Y, Gao Y, Pi G, Wang X, Ke D, Wang JZ. Alzheimer-like tau accumulation in dentate gyrus mossy cells induces spatial cognitive deficits by disrupting multiple memory-related signaling and inhibiting local neural circuit. Aging Cell 2022;21:e13600. [PMID: 35355405 DOI: 10.1111/acel.13600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
232 Zong X, Gu J, Geng D, Gao D. Repetitive transcranial magnetic stimulation (rTMS) for multiple neurological conditions in rodent animal models: A systematic review. Neurochemistry International 2022. [DOI: 10.1016/j.neuint.2022.105356] [Reference Citation Analysis]
233 Chen X, Wang T, Lai H, Zhang X, Feng Q, Huang M. Structure-constrained combination-based nonlinear association analysis between incomplete multimodal imaging and genetic data for biomarker detection of neurodegenerative diseases. Medical Image Analysis 2022;78:102419. [DOI: 10.1016/j.media.2022.102419] [Reference Citation Analysis]
234 Ma Y, Chen H, Liu C, Feng Q, Feng L, Zhang Y, Hu H, Dong Q, Tan L, Kan H, Zhang C, Suckling J, Zeng Y, Chen R, Yu J. Association of long-term exposure to ambient air pollution with cognitive decline and Alzheimer’s disease-related amyloidosis. Biological Psychiatry 2022. [DOI: 10.1016/j.biopsych.2022.05.017] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
235 Chen X, Ren G, Li Y, Chao W, Chen S, Li X, Xue S. Level of LncRNA GAS5 and Hippocampal Volume are Associated with the Progression of Alzheimer’s Disease. CIA 2022;Volume 17:745-53. [DOI: 10.2147/cia.s363116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Brucki SMD, César-freitas KG, Spera RR, Borges CR, Smid J. Are we ready to use anti-amyloid therapy in Alzheimer's disease? Arq Neuro-Psiquiatr 2022;80:15-23. [DOI: 10.1590/0004-282x-anp-2022-s117] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
237 Sekino N, Selim M, Shehadah A. Sepsis-associated brain injury: underlying mechanisms and potential therapeutic strategies for acute and long-term cognitive impairments. J Neuroinflammation 2022;19:101. [PMID: 35488237 DOI: 10.1186/s12974-022-02464-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
238 Mai Z, Wei W, Yu H, Chen Y, Wang Y, Ding Y. Molecular recognition of the interaction between ApoE and the TREM2 protein. Translational Neuroscience 2022;13:93-103. [DOI: 10.1515/tnsci-2022-0218] [Reference Citation Analysis]
239 Bonanni R, Cariati I, Tarantino U, D’arcangelo G, Tancredi V. Physical Exercise and Health: A Focus on Its Protective Role in Neurodegenerative Diseases. JFMK 2022;7:38. [DOI: 10.3390/jfmk7020038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
240 Mai Y, Cao Z, Xu J, Yu Q, Yang S, Tang J, Zhao L, Fang W, Luo Y, Lei M, Mok VCT, Shi L, Liao W, Liu J; the Alzheimer’s Disease Neuroimaging Initiative. AD Resemblance Atrophy Index of Brain Magnetic Resonance Imaging in Predicting the Progression of Mild Cognitive Impairment Carrying Apolipoprotein E-ε4 Allele. Front Aging Neurosci 2022;14:859492. [DOI: 10.3389/fnagi.2022.859492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
241 Therriault J, Pascoal TA, Lussier FZ, Tissot C, Chamoun M, Bezgin G, Servaes S, Benedet AL, Ashton NJ, Karikari TK, Lantero-rodriguez J, Kunach P, Wang Y, Fernandez-arias J, Massarweh G, Vitali P, Soucy J, Saha-chaudhuri P, Blennow K, Zetterberg H, Gauthier S, Rosa-neto P. Biomarker modeling of Alzheimer’s disease using PET-based Braak staging. Nat Aging. [DOI: 10.1038/s43587-022-00204-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
242 Zhang Z, Cao X, Peng J, Huang S, Chen C, Jia S, Ni J, Song G. Reversal of Lipid Metabolism Dysregulation by Selenium and Folic Acid Co-Supplementation to Mitigate Pathology in Alzheimer’s Disease. Antioxidants 2022;11:829. [DOI: 10.3390/antiox11050829] [Reference Citation Analysis]
243 Maschio C, Ni R. Amyloid and Tau Positron Emission Tomography Imaging in Alzheimer’s Disease and Other Tauopathies. Front Aging Neurosci 2022;14:838034. [DOI: 10.3389/fnagi.2022.838034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
244 Ortiz YT, Mcmahon LR, Wilkerson JL. Medicinal Cannabis and Central Nervous System Disorders. Front Pharmacol 2022;13:881810. [DOI: 10.3389/fphar.2022.881810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
245 Lu WH, Giudici KV, Morley JE, Guyonnet S, Parini A, Aggarwal G, Nguyen AD, Li Y, Bateman RJ, Vellas B, de Souto Barreto P; MAPT/DSA Group. Investigating the combination of plasma amyloid-beta and geroscience biomarkers on the incidence of clinically meaningful cognitive decline in older adults. Geroscience 2022. [PMID: 35445358 DOI: 10.1007/s11357-022-00554-y] [Reference Citation Analysis]
246 Gonzalez-Gil A, Porell RN, Fernandes SM, Maenpaa E, August Li T, Li T, Wong PC, Aoki K, Tiemeyer M, Yu ZJ, Orsburn BC, Bumpus NN, Matthews RT, Schnaar RL. Human brain sialoglycan ligand for CD33, a microglial inhibitory Siglec implicated in Alzheimer's disease. J Biol Chem 2022;:101960. [PMID: 35452678 DOI: 10.1016/j.jbc.2022.101960] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
247 Sheng C, Yang K, He B, Li T, Wang X, Du W, Hu X, Jiang J, Jiang X, Jessen F, Han Y. Cross-Cultural Longitudinal Study on Cognitive Decline (CLoCODE) for Subjective Cognitive Decline in China and Germany: A Protocol for Study Design. JAD 2022. [DOI: 10.3233/jad-215452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
248 Kobayashi Y, Kohbuchi S, Koganezawa N, Sekino Y, Shirao T, Saido TC, Saito T, Saito Y. Impairment of ciliary dynamics in an APP knock-in mouse model of Alzheimer's disease. Biochem Biophys Res Commun 2022;610:85-91. [PMID: 35453040 DOI: 10.1016/j.bbrc.2022.04.050] [Reference Citation Analysis]
249 Wang Q, Duan L, Li X, Wang Y, Guo W, Guan F, Ma S. Glucose Metabolism, Neural Cell Senescence and Alzheimer’s Disease. IJMS 2022;23:4351. [DOI: 10.3390/ijms23084351] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
250 Lampinen R, Górová V, Avesani S, Liddell JR, Penttilä E, Závodná T, Krejčík Z, Lehtola JM, Saari T, Kalapudas J, Hannonen S, Löppönen H, Topinka J, Koivisto AM, White AR, Giugno R, Kanninen KM. Biometal Dyshomeostasis in Olfactory Mucosa of Alzheimer's Disease Patients. Int J Mol Sci 2022;23:4123. [PMID: 35456941 DOI: 10.3390/ijms23084123] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
251 Pemberton HG, Collij LE, Heeman F, Bollack A, Shekari M, Salvadó G, Alves IL, Garcia DV, Battle M, Buckley C, Stephens AW, Bullich S, Garibotto V, Barkhof F, Gispert JD, Farrar G; AMYPAD consortium. Quantification of amyloid PET for future clinical use: a state-of-the-art review. Eur J Nucl Med Mol Imaging 2022. [PMID: 35389071 DOI: 10.1007/s00259-022-05784-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
252 Chen F, Bai J, Zhong S, Zhang R, Zhang X, Xu Y, Zhao M, Zhao C, Zhou Z, Villa C. Molecular Signatures of Mitochondrial Complexes Involved in Alzheimer’s Disease via Oxidative Phosphorylation and Retrograde Endocannabinoid Signaling Pathways. Oxidative Medicine and Cellular Longevity 2022;2022:1-12. [DOI: 10.1155/2022/9565545] [Reference Citation Analysis]
253 Huang X, Zhang S, Li B, Zhao X, Xu J, Cao T, Wan Q. The feasibility and efficacy of the home-based exercise programs in patients with cognitive impairment: A pilot study. Geriatr Nurs 2022;45:108-17. [PMID: 35395598 DOI: 10.1016/j.gerinurse.2022.03.010] [Reference Citation Analysis]
254 Botros AA, Schuetz N, Röcke C, Weibel R, Martin M, Müri RM, Nef T. Eigenbehaviour as an Indicator of Cognitive Abilities. Sensors 2022;22:2769. [DOI: 10.3390/s22072769] [Reference Citation Analysis]
255 Hu S, Yang C, Luo H. Current trends in blood biomarker detection and imaging for Alzheimer’s disease. Biosensors and Bioelectronics 2022. [DOI: 10.1016/j.bios.2022.114278] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
256 Li H, Zou L, Li XY, Wu DT, Liu HY, Li HB, Gan RY. Adzuki bean (Vigna angularis): Chemical compositions, physicochemical properties, health benefits, and food applications. Compr Rev Food Sci Food Saf 2022. [PMID: 35365946 DOI: 10.1111/1541-4337.12945] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
257 Liu H, Huo X, Wang S, Yin Z. The inhibitory effects of natural antioxidants on protein glycation as well as aggregation induced by methylglyoxal and underlying mechanisms. Colloids Surf B Biointerfaces 2022;212:112360. [PMID: 35131714 DOI: 10.1016/j.colsurfb.2022.112360] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 Zhang Y, Ren R, Yang L, Zhang H, Shi Y, Okhravi HR, Vitiello MV, Sanford LD, Tang X. Sleep in Alzheimer's disease: a systematic review and meta-analysis of polysomnographic findings. Transl Psychiatry 2022;12:136. [PMID: 35365609 DOI: 10.1038/s41398-022-01897-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
259 Chételat G. How to use neuroimaging biomarkers in the diagnosis framework of neurodegenerative diseases? Revue Neurologique 2022. [DOI: 10.1016/j.neurol.2022.03.006] [Reference Citation Analysis]
260 Xiao X, Liao X, Zhou Y, Weng L, Guo L, Zhou L, Wang X, Liu X, Liu H, Bi X, Xu T, Zhu Y, Yang Q, Zhang S, Hao X, Liu Y, Zhang W, Li J, Shen L, Jiao B. Variants in the Niemann-Pick type C genes are not associated with Alzheimer's disease: A large case-control study in the Chinese Population. Neurobiology of Aging 2022. [DOI: 10.1016/j.neurobiolaging.2022.04.008] [Reference Citation Analysis]
261 Scheltens P, Haan WD, Jutten RJ, Vijverberg E, Wilde AD, Prins N. The Importance of Phase 2 in Drug Development for Alzheimer’s Disease. Alzheimer's Disease Drug Development 2022. [DOI: 10.1017/9781108975759.013] [Reference Citation Analysis]
262 Ross EL, Weinberg MS, Arnold SE. Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease in the US. JAMA Neurol 2022. [PMID: 35344024 DOI: 10.1001/jamaneurol.2022.0315] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
263 Lissaman R, Lancaster TM, Parker GD, Graham KS, Lawrence AD, Hodgetts CJ. Tract-specific white matter microstructure alterations among young adult APOE ε4 carriers: A replication and extension study.. [DOI: 10.1101/2022.03.23.485532] [Reference Citation Analysis]
264 Gates EJ, Bernath AK, Klegeris A. Modifying the diet and gut microbiota to prevent and manage neurodegenerative diseases. Rev Neurosci 2022. [PMID: 35304983 DOI: 10.1515/revneuro-2021-0146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
265 Jian JM, Fan DY, Cheng Y, Shen YY, Chen DW, Li HY, Chen Y, Zhang Y, Zeng GH, Tan CR, Liu YH, Wang YJ. Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's Disease. J Alzheimers Dis 2022. [PMID: 35342089 DOI: 10.3233/JAD-215611] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
266 Luppi JJ, Schoonhoven DN, van Nifterick AM, Gouw AA, Hillebrand A, Scheltens P, Stam CJ, de Haan W. Oscillatory Activity of the Hippocampus in Prodromal Alzheimer’s Disease: A Source-Space Magnetoencephalography Study. JAD 2022. [DOI: 10.3233/jad-215464] [Reference Citation Analysis]
267 Zhu C, Yang Y, Li X, Chen X, Lin X, Wu X. Develop potential multi-target drugs by self-assembly of quercetin with amino acids and metal ion to achieve significant efficacy in anti-Alzheimer’s disease. Nano Res . [DOI: 10.1007/s12274-021-4066-8] [Reference Citation Analysis]
268 Xiao Y, Gong X, Deng R, Liu W, Yang Y, Wang X, Wang J, Bao J, Shu X, Gong C. Iron Chelation Remits Memory Deficits Caused by the High-Fat Diet in a Mouse Model of Alzheimer’s Disease. JAD 2022. [DOI: 10.3233/jad-215705] [Reference Citation Analysis]
269 Aaldijk E, Vermeiren Y. The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer's disease: A narrative review. Ageing Res Rev 2022;75:101556. [PMID: 34990844 DOI: 10.1016/j.arr.2021.101556] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
270 Kalinichenko LS, Gulbins E, Kornhuber J, Müller CP. Sphingolipid control of cognitive functions in health and disease. Progress in Lipid Research 2022. [DOI: 10.1016/j.plipres.2022.101162] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
271 Mishra S, Knupp A, Szabo MP, Williams CA, Kinoshita C, Hailey DW, Wang Y, Andersen OM, Young JE. The Alzheimer's gene SORL1 is a regulator of endosomal traffic and recycling in human neurons. Cell Mol Life Sci 2022;79:162. [PMID: 35226190 DOI: 10.1007/s00018-022-04182-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
272 Shadfar S, Brocardo M, Atkin JD. The Complex Mechanisms by Which Neurons Die Following DNA Damage in Neurodegenerative Diseases. Int J Mol Sci 2022;23:2484. [PMID: 35269632 DOI: 10.3390/ijms23052484] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
273 Hua X, Church K, Walker W, L'Hostis P, Viardot G, Danjou P, Hendrix S, Moebius HJ. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial. J Alzheimers Dis 2022. [PMID: 35180125 DOI: 10.3233/JAD-215511] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
274 Verde F. Tau proteins in blood as biomarkers of Alzheimer's disease and other proteinopathies. J Neural Transm (Vienna) 2022. [PMID: 35175385 DOI: 10.1007/s00702-022-02471-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
275 Zhou Z, Chen S, Huang Y, Gu B, Li J, Wu C, Yin P, Zhang Y, Li H. Simultaneous visualization and quantification of copper (II) ions in Alzheimer's disease by a near-infrared fluorescence probe. Biosens Bioelectron 2022;198:113858. [PMID: 34871835 DOI: 10.1016/j.bios.2021.113858] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
276 Li T, Li X, Huang X, Yu H, Li S, Zhang Z, Xie Y, Song X, Liu J, Yang X, Liu G. Mitochondriomics reveals the underlying neuroprotective mechanism of TrkB receptor agonist R13 in the 5×FAD mice. Neuropharmacology 2022;204:108899. [PMID: 34838815 DOI: 10.1016/j.neuropharm.2021.108899] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
277 Xing J, Jia J, Wu X, Kuang L. A Spatiotemporal Brain Network Analysis of Alzheimer’s Disease Based on Persistent Homology. Front Aging Neurosci 2022;14:788571. [DOI: 10.3389/fnagi.2022.788571] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
278 Astillero-Lopez V, Gonzalez-Rodriguez M, Villar-Conde S, Flores-Cuadrado A, Martinez-Marcos A, Ubeda-Banon I, Saiz-Sanchez D. Neurodegeneration and astrogliosis in the entorhinal cortex in Alzheimer's disease: Stereological layer-specific assessment and proteomic analysis. Alzheimers Dement 2022. [PMID: 35142030 DOI: 10.1002/alz.12580] [Reference Citation Analysis]
279 Lai C, Chen Z, Ding Y, Chen Q, Su S, Liu H, Ni R, Tang Z. Rapamycin Attenuated Zinc-Induced Tau Phosphorylation and Oxidative Stress in Rats: Involvement of Dual mTOR/p70S6K and Nrf2/HO-1 Pathways. Front Immunol 2022;13:782434. [DOI: 10.3389/fimmu.2022.782434] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
280 Delaby C, Estellés T, Zhu N, Arranz J, Barroeta I, Carmona-Iragui M, Illán-Gala I, Santos-Santos MÁ, Altuna M, Sala I, Sánchez-Saudinós MB, Videla L, Valldeneu S, Subirana A, Tondo M, Blanco-Vaca F, Lehmann S, Belbin O, Blesa R, Fortea J, Lleó A, Alcolea D. The Aβ1-42/Aβ1-40 ratio in CSF is more strongly associated to tau markers and clinical progression than Aβ1-42 alone. Alzheimers Res Ther 2022;14:20. [PMID: 35105351 DOI: 10.1186/s13195-022-00967-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
281 Fertan E, Brown RE. Age-Related Deficits in Working Memory in 5xFAD Mice in the Hebb-Williams Maze. Behavioural Brain Research 2022. [DOI: 10.1016/j.bbr.2022.113806] [Reference Citation Analysis]
282 Arbo BD, Schimith LE, Goulart dos Santos M, Hort MA. Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174800] [Reference Citation Analysis]
283 Chen Y, Hu D, Zhao L, Tang W, Li B. Unraveling metabolic alterations in transgenic mouse model of Alzheimer's disease using MALDI MS imaging with 4-aminocinnoline-3-carboxamide matrix. Anal Chim Acta 2022;1192:339337. [PMID: 35057932 DOI: 10.1016/j.aca.2021.339337] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
284 Yan X, Liu H, Hong Y, Meng T, Du J, Chang C. lncRNA XIST induces Aβ accumulation and neuroinflammation by the epigenetic repression of NEP in Alzheimer’s disease. Journal of Neurogenetics. [DOI: 10.1080/01677063.2022.2028784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
285 Holmer J, Eriksdotter M, Häbel H, Hed Myrberg I, Jonsson A, Pussinen PJ, Garcia‐ptacek S, Jansson L, Sandborgh‐englund G, Buhlin K. Periodontal conditions and incident dementia: A nationwide Swedish cohort study. Journal of Periodontology. [DOI: 10.1002/jper.21-0518] [Reference Citation Analysis]
286 Schumacher-schuh A, Bieger A, Borelli WV, Portley MK, Awad PS, Bandres-ciga S. Advances in Proteomic and Metabolomic Profiling of Neurodegenerative Diseases. Front Neurol 2022;12:792227. [DOI: 10.3389/fneur.2021.792227] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
287 Jansen WJ, Janssen O, Tijms BM, Vos SJB, Ossenkoppele R, Visser PJ, Aarsland D, Alcolea D, Altomare D, von Arnim C, Baiardi S, Baldeiras I, Barthel H, Bateman RJ, Van Berckel B, Binette AP, Blennow K, Boada M, Boecker H, Bottlaender M, den Braber A, Brooks DJ, Van Buchem MA, Camus V, Carill JM, Cerman J, Chen K, Chételat G, Chipi E, Cohen AD, Daniels A, Delarue M, Didic M, Drzezga A, Dubois B, Eckerström M, Ekblad LL, Engelborghs S, Epelbaum S, Fagan AM, Fan Y, Fladby T, Fleisher AS, Van der Flier WM, Förster S, Fortea J, Frederiksen KS, Freund-Levi Y, Frings L, Frisoni GB, Fröhlich L, Gabryelewicz T, Gertz HJ, Gill KD, Gkatzima O, Gómez-Tortosa E, Grimmer T, Guedj E, Habeck CG, Hampel H, Handels R, Hansson O, Hausner L, Hellwig S, Heneka MT, Herukka SK, Hildebrandt H, Hodges J, Hort J, Huang CC, Iriondo AJ, Itoh Y, Ivanoiu A, Jagust WJ, Jessen F, Johannsen P, Johnson KA, Kandimalla R, Kapaki EN, Kern S, Kilander L, Klimkowicz-Mrowiec A, Klunk WE, Koglin N, Kornhuber J, Kramberger MG, Kuo HC, Van Laere K, Landau SM, Landeau B, Lee DY, de Leon M, Leyton CE, Lin KJ, Lleó A, Löwenmark M, Madsen K, Maier W, Marcusson J, Marquié M, Martinez-Lage P, Maserejian N, Mattsson N, de Mendonça A, Meyer PT, Miller BL, Minatani S, Mintun MA, Mok VCT, Molinuevo JL, Morbelli SD, Morris JC, Mroczko B, Na DL, Newberg A, Nobili F, Nordberg A, Olde Rikkert MGM, de Oliveira CR, Olivieri P, Orellana A, Paraskevas G, Parchi P, Pardini M, Parnetti L, Peters O, Poirier J, Popp J, Prabhakar S, Rabinovici GD, Ramakers IH, Rami L, Reiman EM, Rinne JO, Rodrigue KM, Rodríguez-Rodriguez E, Roe CM, Rosa-Neto P, Rosen HJ, Rot U, Rowe CC, Rüther E, Ruiz A, Sabri O, Sakhardande J, Sánchez-Juan P, Sando SB, Santana I, Sarazin M, Scheltens P, Schröder J, Selnes P, Seo SW, Silva D, Skoog I, Snyder PJ, Soininen H, Sollberger M, Sperling RA, Spiru L, Stern Y, Stomrud E, Takeda A, Teichmann M, Teunissen CE, Thompson LI, Tomassen J, Tsolaki M, Vandenberghe R, Verbeek MM, Verhey FRJ, Villemagne V, Villeneuve S, Vogelgsang J, Waldemar G, Wallin A, Wallin ÅK, Wiltfang J, Wolk DA, Yen TC, Zboch M, Zetterberg H; Amyloid Biomarker Study Group. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum. JAMA Neurol 2022. [PMID: 35099509 DOI: 10.1001/jamaneurol.2021.5216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
288 Jullienne A, Trinh MV, Obenaus A. Neuroimaging of Mouse Models of Alzheimer’s Disease. Biomedicines 2022;10:305. [DOI: 10.3390/biomedicines10020305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
289 Hong L, Zeng Q, Li K, Luo X, Xu X, Liu X, Li Z, Fu Y, Wang Y, Zhang T, Chen Y, Liu Z, Huang P, Zhang M. Intrinsic Brain Activity of Inferior Temporal Region Increased in Prodromal Alzheimer's Disease With Hearing Loss. Front Aging Neurosci 2022;13:772136. [DOI: 10.3389/fnagi.2021.772136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
290 Bao J, Liang Z, Gong X, Zhao Y, Wu M, Liu W, Tu C, Wang X, Shu X. Tangeretin Inhibits BACE1 Activity and Attenuates Cognitive Impairments in AD Model Mice. J Agric Food Chem 2022. [PMID: 35084179 DOI: 10.1021/acs.jafc.1c07241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
291 Benson GS, Bauer C, Hausner L, Couturier S, Lewczuk P, Peters O, Hüll M, Jahn H, Jessen F, Pantel J, Teipel SJ, Wagner M, Schuchhardt J, Wiltfang J, Kornhuber J, Frölich L. Don’t forget about tau: the effects of ApoE4 genotype on Alzheimer’s disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment—data from the Dementia Competence Network. J Neural Transm. [DOI: 10.1007/s00702-022-02461-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
292 Ni R, Nitsch RM. Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia. Front Aging Neurosci 2021;13:751897. [PMID: 35046791 DOI: 10.3389/fnagi.2021.751897] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
293 Yang Z, Sheng X, Qin R, Chen H, Shao P, Xu H, Yao W, Zhao H, Xu Y, Bai F. Cognitive Improvement via Left Angular Gyrus-Navigated Repetitive Transcranial Magnetic Stimulation Inducing the Neuroplasticity of Thalamic System in Amnesic Mild Cognitive Impairment Patients. JAD 2022. [DOI: 10.3233/jad-215390] [Reference Citation Analysis]
294 Lin L, Jhao Y, Chiu C, Sun L, Chou T, Shiue C, Cheng C, Ma K. Bezafibrate Exerts Neuroprotective Effects in a Rat Model of Sporadic Alzheimer’s Disease. Pharmaceuticals 2022;15:109. [DOI: 10.3390/ph15020109] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
295 Urso D, Gnoni V, Filardi M, Logroscino G. Delusion and Delirium in Neurodegenerative Disorders: An Overlooked Relationship? Front Psychiatry 2022;12:808724. [DOI: 10.3389/fpsyt.2021.808724] [Reference Citation Analysis]
296 Gao Y, Liu J, Wang J, Liu Y, Zeng LH, Ge W, Ma C. Proteomic analysis of human hippocampal subfields provides new insights into the pathogenesis of Alzheimer's disease and the role of glial cells. Brain Pathol 2022;:e13047. [PMID: 35016256 DOI: 10.1111/bpa.13047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
297 Zhang T, Xia Y, Hu L, Chen D, Gan CL, Wang L, Mei Y, Lan G, Shui X, Tian Y, Li R, Zhang M, Lee TH. Death-associated protein kinase 1 mediates Aβ42 aggregation-induced neuronal apoptosis and tau dysregulation in Alzheimer's disease. Int J Biol Sci 2022;18:693-706. [PMID: 35002518 DOI: 10.7150/ijbs.66760] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
298 Cho HJ. Is essential tremor a degenerative or an electrical disorder? Electrical disorder. International Review of Neurobiology 2022. [DOI: 10.1016/bs.irn.2022.02.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
299 Toledo JB, Liu H, Grothe MJ, Rashid T, Launer L, Shaw LM, Snoussi H, Heckbert S, Weiner M, Trojanwoski JQ, Seshadri S, Habes M, & for the Alzheimer's Disease Neuroimaging Initiative. Disentangling tau and brain atrophy cluster heterogeneity across the Alzheimer's disease continuum. A&D Transl Res & Clin Interv 2022;8. [DOI: 10.1002/trc2.12305] [Reference Citation Analysis]
300 den Haan J, Hart de Ruyter FJ, Lochocki B, Kroon MA, Kemper EM, Teunissen CE, van Berckel B, Scheltens P, Hoozemans JJ, de Kreeke AV, Verbraak FD, de Boer JF, Bouwman FH. No difference in retinal fluorescence after oral curcumin intake in amyloid‐proven AD cases compared to controls. Alz & Dem Diag Ass & Dis Mo 2022;14. [DOI: 10.1002/dad2.12347] [Reference Citation Analysis]
301 许 斯. Study on the Effect of Blood Pressure on the Physiological Mechanism of Alzheimer’s Disease. ACM 2022;12:10059-10066. [DOI: 10.12677/acm.2022.12111451] [Reference Citation Analysis]
302 Cortes-canteli M, Perez-castillo A. Alzheimer׳s Disease: One of the Pandemics of the 21st Century. Reference Module in Life Sciences 2022. [DOI: 10.1016/b978-0-12-821618-7.00247-9] [Reference Citation Analysis]
303 Sanz C, Carrillo F, Slachevsky A, Forno G, Gorno Tempini ML, Villagra R, Ibáñez A, Tagliazucchi E, García AM. Automated text‐level semantic markers of Alzheimer's disease. Alz & Dem Diag Ass & Dis Mo 2022;14. [DOI: 10.1002/dad2.12276] [Reference Citation Analysis]
304 Russell AE, Badr A, Rai A, Carafice C, Rai A, Daily KP, Whitham O, Amer AO, Brown CM, Dakhlallah D. Crosstalk Between Autophagy and Nutrigenomics in Neurodegenerative Diseases. Nutritional Neurosciences 2022. [DOI: 10.1007/978-981-16-9205-5_13] [Reference Citation Analysis]
305 Simrén J, Elmgren A, Blennow K, Zetterberg H. Fluid biomarkers in Alzheimer's disease. Advances in Clinical Chemistry 2022. [DOI: 10.1016/bs.acc.2022.09.006] [Reference Citation Analysis]
306 Winchester L, Lawton M, Barber I, Ash J, Liu B, Evetts S, Hopkins-jones L, Lewis S, Bresner C, Vingill S, Malpartida AB, Williams N, Gentlemen S, Wade-martins R, Ryan B, Holgado-nevado A, Hu M, Ben-shlomo Y, Grosset D, Lovestone S. Identification of a novel proteomic Biomarker in Parkinson’s Disease: Discovery and Replication in Blood, brain and CSF.. [DOI: 10.1101/2021.12.26.21268282] [Reference Citation Analysis]
307 Ong-Pålsson E, Njavro JR, Wilson Y, Pigoni M, Schmidt A, Müller SA, Meyer M, Hartmann J, Busche MA, Gunnersen JM, Munro KM, Lichtenthaler SF. The β-Secretase Substrate Seizure 6-Like Protein (SEZ6L) Controls Motor Functions in Mice. Mol Neurobiol 2021. [PMID: 34958451 DOI: 10.1007/s12035-021-02660-y] [Reference Citation Analysis]
308 Policarpo R, d’Ydewalle C. Missing lnc(RNAs) in Alzheimer’s Disease? Genes 2021;13:39. [DOI: 10.3390/genes13010039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
309 Li Y, Fan H, Ni M, Zhang W, Fang F, Sun J, Lyu P, Ma P. Etanercept Reduces Neuron Injury and Neuroinflammation via Inactivating c-Jun N-terminal Kinase and Nuclear Factor-κB Pathways in Alzheimer's Disease: An In Vitro and In Vivo Investigation. Neuroscience 2021:S0306-4522(21)00551-0. [PMID: 35058089 DOI: 10.1016/j.neuroscience.2021.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
310 Delaby C, Teunissen CE, Blennow K, Alcolea D, Arisi I, Amar EB, Beaume A, Bedel A, Bellomo G, Bigot‐corbel E, Bjerke M, Blanc‐quintin M, Boada M, Bousiges O, Chapman MD, Demarco ML, D'onofrio M, Dumurgier J, Dufour‐rainfray D, Engelborghs S, Esselmann H, Fogli A, Gabelle A, Galloni E, Gondolf C, Grandhomme F, Grau‐rivera O, Hart M, Ikeuchi T, Jeromin A, Kasuga K, Keshavan A, Khalil M, Körtvelyessy P, Kulczynska‐przybik A, Laplanche J, Lewczuk P, Li Q, Lleó A, Malaplate C, Marquié M, Masters CL, Mroczko B, Nogueira L, Orellana A, Otto M, Oudart J, Paquet C, Paoletti FP, Parnetti L, Perret‐liaudet A, Peoc'h K, Poesen K, Puig‐pijoan A, Quadrio I, Quillard‐muraine M, Rucheton B, Schraen S, Schott JM, Shaw LM, Suárez‐calvet M, Tsolaki M, Tumani H, Udeh‐momoh CT, Vaudran L, Verbeek MM, Verde F, Vermunt L, Vogelgsang J, Wiltfang J, Zetterberg H, Lehmann S. Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview. Alzheimer's & Dementia. [DOI: 10.1002/alz.12545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
311 Zhao Y, Bao J, Liu W, Gong X, Liang Z, Li W, Wu M, Xiao Y, Sun B, Wang X, Wang J, Wang J, Shu X, Gong C. Spatial Training Attenuates Long-Term Alzheimer’s Disease-Related Pathogenic Processes in APP/PS1 Mice. JAD 2021. [DOI: 10.3233/jad-215016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
312 Imbimbo BP, Watling M. What have we learned from past failures of investigational drugs for Alzheimer's disease? Expert Opin Investig Drugs 2021;:1-8. [PMID: 34890262 DOI: 10.1080/13543784.2021.2017881] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
313 You M, Zhou X, Yin W, Wan K, Zhang W, Li C, Li M, Zhu W, Zhu X, Sun Z. The Influence of MTHFR Polymorphism on Gray Matter Volume in Patients With Amnestic Mild Cognitive Impairment. Front Neurosci 2021;15:778123. [PMID: 34916904 DOI: 10.3389/fnins.2021.778123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
314 Wang Y, Grydeland H, Roe JM, Pan M, Magnussen F, Amlien IK, Watne LO, Idland AV, Bertram L, Gundersen TE, Pascual-Leone A, Cabello-Toscano M, Tormos JM, Bartres-Faz D, Drevon CA, Fjell AM, Walhovd KW. Associations of circulating C-reactive proteins, APOE ε4, and brain markers for Alzheimer's disease in healthy samples across the lifespan. Brain Behav Immun 2021;100:243-53. [PMID: 34920091 DOI: 10.1016/j.bbi.2021.12.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
315 Li Q, Zhang Q, Zhang S, Du M, Wang X, Hu S, Li L. Relationship between frailty and cognitive decline in Chinese older patients with Alzheimer's disease: The mediating role of social contact. Geriatr Nurs 2021;43:175-81. [PMID: 34911018 DOI: 10.1016/j.gerinurse.2021.11.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
316 Li M, Liu M, Sha Y. Induced and Inversed Circularly Polarized Luminescence of Achiral Thioflavin T Assembled on Peptide Fibril. Small 2021;:e2106130. [PMID: 34881501 DOI: 10.1002/smll.202106130] [Reference Citation Analysis]
317 Szabo MP, Mishra S, Knupp A, Young JE. The role of Alzheimer's disease risk genes in endolysosomal pathways. Neurobiol Dis 2022;162:105576. [PMID: 34871734 DOI: 10.1016/j.nbd.2021.105576] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
318 Yang X, Zhao X, Zhao H, Liu F, Zhang S, Zhang CX, Yang Z. Combination of liquid crystal and deep learning reveals distinct signatures of Parkinson's disease-related wild-type α-synuclein and six pathogenic mutants. Chem Asian J 2021;:e202101251. [PMID: 34877798 DOI: 10.1002/asia.202101251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
319 Ossenkoppele R, Singleton EH, Groot C, Dijkstra AA, Eikelboom WS, Seeley WW, Miller B, Laforce RJ, Scheltens P, Papma JM, Rabinovici GD, Pijnenburg YAL. Research Criteria for the Behavioral Variant of Alzheimer Disease: A Systematic Review and Meta-analysis. JAMA Neurol 2021. [PMID: 34870696 DOI: 10.1001/jamaneurol.2021.4417] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 12.0] [Reference Citation Analysis]
320 Bayoumy S, Verberk IMW, den Dulk B, Hussainali Z, Zwan M, van der Flier WM, Ashton NJ, Zetterberg H, Blennow K, Vanbrabant J, Stoops E, Vanmechelen E, Dage JL, Teunissen CE. Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231. Alzheimers Res Ther 2021;13:198. [PMID: 34863295 DOI: 10.1186/s13195-021-00939-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 23.0] [Reference Citation Analysis]
321 van Gils AM, Visser LN, Hendriksen HM, Georges J, Muller M, Bouwman FH, van der Flier WM, Rhodius-Meester HF. Assessing the Views of Professionals, Patients, and Care Partners Concerning the Use of Computer Tools in Memory Clinics: International Survey Study. JMIR Form Res 2021;5:e31053. [PMID: 34870612 DOI: 10.2196/31053] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
322 Liu XX, Wu PF, Liu YZ, Jiang YL, Wan MD, Xiao XW, Yang QJ, Jiao B, Liao XX, Wang JL, Liu SH, Zhang X, Shen L. Association Between Serum Vitamins and the Risk of Alzheimer's Disease in Chinese Population. J Alzheimers Dis 2021. [PMID: 34864672 DOI: 10.3233/JAD-215104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
323 Sáez CZ, Espeso ER, Jentoft LHSYAC. El deterioro cognitivo en los mayores. Medicine - Programa de Formación Médica Continuada Acreditado 2021;13:2671-2687. [DOI: 10.1016/j.med.2021.12.002] [Reference Citation Analysis]
324 Simoes S, Guo J, Buitrago L, Qureshi YH, Feng X, Kothiya M, Cortes E, Patel V, Kannan S, Kim Y, Chang K, Hussaini SA, Moreno H, Di Paolo G, Andersen OM, Small SA. Alzheimer's vulnerable brain region relies on a distinct retromer core dedicated to endosomal recycling. Cell Reports 2021;37:110182. [DOI: 10.1016/j.celrep.2021.110182] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
325 Bao J, Liang Z, Gong X, Yu J, Xiao Y, Liu W, Wang X, Wang JZ, Shu X. High Fat Diet Mediates Amyloid-β Cleaving Enzyme 1 Phosphorylation and SUMOylation, Enhancing Cognitive Impairment in APP/PS1 Mice. J Alzheimers Dis 2021. [PMID: 34864680 DOI: 10.3233/JAD-215299] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
326 Teunissen CE, Verberk IMW, Thijssen EH, Vermunt L, Hansson O, Zetterberg H, van der Flier WM, Mielke MM, Del Campo M. Blood-based biomarkers for Alzheimer's disease: towards clinical implementation. Lancet Neurol 2022;21:66-77. [PMID: 34838239 DOI: 10.1016/S1474-4422(21)00361-6] [Cited by in Crossref: 64] [Cited by in F6Publishing: 80] [Article Influence: 64.0] [Reference Citation Analysis]
327 Vigneswaran J, Muthukumar SA, Shafras M, Pant G. An insight into Alzheimer’s disease and its on-setting novel genes. Egypt J Neurol Psychiatry Neurosurg 2021;57. [DOI: 10.1186/s41983-021-00420-2] [Reference Citation Analysis]
328 Chen L, Shen Q, Xu S, Yu H, Pei S, Zhang Y, He X, Wang Q, Li D. 5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease. J Alzheimers Dis 2021. [PMID: 34864677 DOI: 10.3233/JAD-215217] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
329 Xin XY, Lai ZH, Ding KQ, Zeng LL, Ma JF. Angiotensin-converting enzyme polymorphisms AND Alzheimer's disease susceptibility: An updated meta-analysis. PLoS One 2021;16:e0260498. [PMID: 34818351 DOI: 10.1371/journal.pone.0260498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
330 Ni R. Magnetic Resonance Imaging in Animal Models of Alzheimer's Disease Amyloidosis. Int J Mol Sci 2021;22:12768. [PMID: 34884573 DOI: 10.3390/ijms222312768] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
331 Lu Y, Li K, Hu Y, Wang X. Expression of Immune Related Genes and Possible Regulatory Mechanisms in Alzheimer's Disease. Front Immunol 2021;12:768966. [PMID: 34804058 DOI: 10.3389/fimmu.2021.768966] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
332 Ni R. Positron Emission Tomography in Animal Models of Alzheimer's Disease Amyloidosis: Translational Implications. Pharmaceuticals (Basel) 2021;14:1179. [PMID: 34832961 DOI: 10.3390/ph14111179] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
333 Dominguez LJ, Veronese N, Vernuccio L, Catanese G, Inzerillo F, Salemi G, Barbagallo M. Nutrition, Physical Activity, and Other Lifestyle Factors in the Prevention of Cognitive Decline and Dementia. Nutrients 2021;13:4080. [PMID: 34836334 DOI: 10.3390/nu13114080] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 14.0] [Reference Citation Analysis]
334 Yun G, Kim HJ, Kim HG, Lee KM, Hong IK, Kim SH, Rhee HY, Jahng GH, Yoon SS, Park KC, Hwang KS, Lee JS. Association Between Plasma Amyloid-β and Neuropsychological Performance in Patients With Cognitive Decline. Front Aging Neurosci 2021;13:736937. [PMID: 34759814 DOI: 10.3389/fnagi.2021.736937] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
335 Toppala S, Ekblad LL, Viitanen M, Rinne JO, Jula A. Oral Glucose Tolerance Test Predicts Episodic Memory Decline: A 10-Year Population-Based Follow-up Study. Diabetes Care 2021;44:2435-7. [PMID: 34762595 DOI: 10.2337/dc21-0042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
336 van Bokhoven P, de Wilde A, Vermunt L, Leferink PS, Heetveld S, Cummings J, Scheltens P, Vijverberg EGB. The Alzheimer's disease drug development landscape. Alzheimers Res Ther 2021;13:186. [PMID: 34763720 DOI: 10.1186/s13195-021-00927-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
337 Wu M, Zhang M, Yin X, Chen K, Hu Z, Zhou Q, Cao X, Chen Z, Liu D. The role of pathological tau in synaptic dysfunction in Alzheimer's diseases. Transl Neurodegener 2021;10:45. [PMID: 34753506 DOI: 10.1186/s40035-021-00270-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 14.0] [Reference Citation Analysis]
338 Haag N, Zempel H. Persistent astrocytic IL-3 stimulation of microglia slows disease in Alzheimer's: treatment perspectives for Alzheimer's. Signal Transduct Target Ther 2021;6:388. [PMID: 34753904 DOI: 10.1038/s41392-021-00806-x] [Reference Citation Analysis]
339 Liu H, Zhang D, Lin H, Zhang Q, Zheng L, Zheng Y, Yin X, Li Z, Liang S, Huang S. Meta-Analysis of Neurochemical Changes Estimated via Magnetic Resonance Spectroscopy in Mild Cognitive Impairment and Alzheimer's Disease. Front Aging Neurosci 2021;13:738971. [PMID: 34744689 DOI: 10.3389/fnagi.2021.738971] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
340 Wang F, Xu J, Xu SJ, Guo JJ, Wang F, Wang QW. Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics. J Alzheimers Dis 2021. [PMID: 34776447 DOI: 10.3233/JAD-215086] [Reference Citation Analysis]
341 Zimmer-Bensch G, Zempel H. DNA Methylation in Genetic and Sporadic Forms of Neurodegeneration: Lessons from Alzheimer's, Related Tauopathies and Genetic Tauopathies. Cells 2021;10:3064. [PMID: 34831288 DOI: 10.3390/cells10113064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
342 Zhang H, Zhang D, Tang K, Sun Q. The Relationship Between Alzheimer's Disease and Skin Diseases: A Review. Clin Cosmet Investig Dermatol 2021;14:1551-60. [PMID: 34729018 DOI: 10.2147/CCID.S322530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
343 Xu J, Green R, Kim M, Lord J, Ebshiana A, Westwood S, Baird AL, Nevado-Holgado AJ, Shi L, Hye A, Snowden SG, Bos I, Vos SJB, Vandenberghe R, Teunissen CE, Kate MT, Scheltens P, Gabel S, Meersmans K, Blin O, Richardson J, De Roeck EE, Engelborghs S, Sleegers K, Bordet R, Rami L, Kettunen P, Tsolaki M, Verhey FRJ, Alcolea D, Lleó A, Peyratout G, Tainta M, Johannsen P, Freund-Levi Y, Frölich L, Dobricic V, Frisoni GB, Molinuevo JL, Wallin A, Popp J, Martinez-Lage P, Bertram L, Blennow K, Zetterberg H, Streffer J, Visser PJ, Lovestone S, Proitsi P, Legido-Quigley C, On Behalf Of The European Medical Information Framework Consortium. Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort. Biomedicines 2021;9:1610. [PMID: 34829839 DOI: 10.3390/biomedicines9111610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
344 Barichello T, Giridharan VV, Comim CM, Morales R. What is the role of microbial infection in Alzheimer's disease? Braz J Psychiatry 2021:S1516-44462021005028201. [PMID: 34730671 DOI: 10.1590/1516-4446-2021-0037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
345 Xiang J, Ran LY, Zeng XX, He WW, Xu Y, Cao K, Dong YT, Qi XL, Yu WF, Xiao Y, Guan ZZ. LiCl attenuates impaired learning and memory of APP/PS1 mice, which in mechanism involves α7 nAChRs and Wnt/β-catenin pathway. J Cell Mol Med 2021;25:10698-710. [PMID: 34708522 DOI: 10.1111/jcmm.17006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
346 Li Y, Laws SM, Miles LA, Wiley JS, Huang X, Masters CL, Gu BJ. Genomics of Alzheimer's disease implicates the innate and adaptive immune systems. Cell Mol Life Sci 2021;78:7397-426. [PMID: 34708251 DOI: 10.1007/s00018-021-03986-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
347 Czapski GA, Strosznajder JB. Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer's Disease. Int J Mol Sci 2021;22:11677. [PMID: 34769106 DOI: 10.3390/ijms222111677] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
348 Xu QQ, Shaw PC, Hu Z, Yang W, Ip SP, Xian YF, Lin ZX. Comparison of the chemical constituents and anti-Alzheimer's disease effects of Uncaria rhynchophylla and Uncaria tomentosa. Chin Med 2021;16:110. [PMID: 34706756 DOI: 10.1186/s13020-021-00514-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
349 Lichtenthaler SF, Tschirner SK, Steiner H. Secretases in Alzheimer's disease: Novel insights into proteolysis of APP and TREM2. Curr Opin Neurobiol 2021;72:101-10. [PMID: 34689040 DOI: 10.1016/j.conb.2021.09.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
350 den Haan J, Hart de Ruyter FJ, Lochocki B, Kroon MA, Kemper EM, Teunissen CE, van Berckel B, Scheltens P, Hoozemans JJ, van de Kreeke A, Verbraak FD, de Boer JF, Bouwman FH. No difference in retinal fluorescence after oral curcumin intake in amyloid proven AD cases compared to controls.. [DOI: 10.1101/2021.10.07.21264420] [Reference Citation Analysis]
351 Pleen J, Townley R. Alzheimer's disease clinical trial update 2019-2021. J Neurol 2021. [PMID: 34609602 DOI: 10.1007/s00415-021-10790-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
352 Cohen PhD ML, Ryan Ma AC, Lanzi PhD Ccc-Slp AM. Prevention of and Early Intervention for Cognitive Decline Due to Alzheimer's Disease and Related Disorders. Dela J Public Health 2021;7:118-22. [PMID: 34604774 DOI: 10.32481/djph.2021.09.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
353 Rujeedawa T, Carrillo Félez E, Clare ICH, Fortea J, Strydom A, Rebillat AS, Coppus A, Levin J, Zaman SH. The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer's Disease. J Clin Med 2021;10:4582. [PMID: 34640600 DOI: 10.3390/jcm10194582] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
354 Li J, Zhang F. Amyloids as Building Blocks for Macroscopic Functional Materials: Designs, Applications and Challenges. Int J Mol Sci 2021;22:10698. [PMID: 34639037 DOI: 10.3390/ijms221910698] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
355 Barranco N, Plá V, Alcolea D, Sánchez-Domínguez I, Fischer-Colbrie R, Ferrer I, Lleó A, Aguado F. Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer's disease. Transl Neurodegener 2021;10:37. [PMID: 34565482 DOI: 10.1186/s40035-021-00263-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
356 Lai C, Ding Y, Chen Q, Su S, Liu H, Ni R, Tang Z. Rapamycin attenuated zinc-induced tau phosphorylation and oxidative stress in animal model: Involvement of dual mTOR/p70S6K and Nrf2/HO-1 pathways.. [DOI: 10.1101/2021.09.24.461637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
357 Xiao X, Guo L, Liao X, Zhou Y, Zhang W, Zhou L, Wang X, Liu X, Liu H, Xu T, Zhu Y, Yang Q, Hao X, Liu Y, Wang J, Li J, Jiao B, Shen L. The role of vascular dementia associated genes in patients with Alzheimer's disease: A large case-control study in the Chinese population. CNS Neurosci Ther 2021;27:1531-9. [PMID: 34551193 DOI: 10.1111/cns.13730] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
358 Perez-nievas BG, Johnson L, Beltran-lobo P, Hughes MM, Gammallieri L, Tarsitano F, Myszczynska MA, Vazquez-villasenor I, Jimenez-sanchez M, Troakes C, Wharton SB, Ferraiuolo L, Noble W. Astrocytic C-X-C motif chemokine ligand-1 mediates β-amyloid-induced synaptotoxicity.. [DOI: 10.1101/2021.09.22.458716] [Reference Citation Analysis]
359 Correia AS, Vale N. Antidepressants in Alzheimer's Disease: A Focus on the Role of Mirtazapine. Pharmaceuticals (Basel) 2021;14:930. [PMID: 34577630 DOI: 10.3390/ph14090930] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
360 Tamagno E, Guglielmotto M, Vasciaveo V, Tabaton M. Oxidative Stress and Beta Amyloid in Alzheimer's Disease. Which Comes First: The Chicken or the Egg? Antioxidants (Basel) 2021;10:1479. [PMID: 34573112 DOI: 10.3390/antiox10091479] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
361 Tinauer C, Heber S, Pirpamer L, Damulina A, Schmidt R, Stollberger R, Ropele S, Langkammer C. Interpretable Brain Disease Classification and Relevance-Guided Deep Learning.. [DOI: 10.1101/2021.09.09.21263013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
362 Ossenkoppele R, Singleton E, Groot C, Dijkstra AA, Eikelboom WS, Seeley WW, Miller B, Laforce R, Scheltens P, Papma J, Rabinovici G, Pijnenburg Y. Provisional research criteria for the behavioral variant of Alzheimer’s disease A systematic review and meta-analysis.. [DOI: 10.1101/2021.09.08.21263253] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
363 Xu X, Du L, Jiang J, Yang M, Wang Z, Wang Y, Tang T, Fu X, Hao J. Microglial TREM2 Mitigates Inflammatory Responses and Neuronal Apoptosis in Angiotensin II-Induced Hypertension in Middle-Aged Mice. Front Aging Neurosci 2021;13:716917. [PMID: 34489683 DOI: 10.3389/fnagi.2021.716917] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
364 O'Neill D, Kennelly S. Responding to responsive behaviour in Alzheimer's disease. Lancet 2021;398:842. [PMID: 34481568 DOI: 10.1016/S0140-6736(21)01452-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
365 Scheltens P. Responding to responsive behaviour in Alzheimer's disease - Author's reply. Lancet 2021;398:842. [PMID: 34481569 DOI: 10.1016/S0140-6736(21)01449-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
366 Remya C, Dileep KV, Koti Reddy E, Mantosh K, Lakshmi K, Sarah Jacob R, Sajith AM, Jayadevi Variyar E, Anwar S, Zhang KYJ, Sadasivan C, Omkumar RV. Neuroprotective derivatives of tacrine that target NMDA receptor and acetyl cholinesterase - Design, synthesis and biological evaluation. Comput Struct Biotechnol J 2021;19:4517-37. [PMID: 34471497 DOI: 10.1016/j.csbj.2021.07.041] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
367 Poor SR, Ettcheto M, Cano A, Sanchez-Lopez E, Manzine PR, Olloquequi J, Camins A, Javan M. Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer's Disease Treatment. Pharmaceuticals (Basel) 2021;14:890. [PMID: 34577590 DOI: 10.3390/ph14090890] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
368 Wang M, Lv J, Huang X, Wisniewski T, Zhang W. High-fat diet-induced atherosclerosis promotes neurodegeneration in the triple transgenic (3 × Tg) mouse model of Alzheimer's disease associated with chronic platelet activation. Alzheimers Res Ther 2021;13:144. [PMID: 34454596 DOI: 10.1186/s13195-021-00890-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
369 Festa BP, Barbosa AD, Rob M, Rubinsztein DC. The pleiotropic roles of autophagy in Alzheimer's disease: From pathophysiology to therapy. Curr Opin Pharmacol 2021;60:149-57. [PMID: 34419832 DOI: 10.1016/j.coph.2021.07.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
370 A Meta-Analysis Study on Alzheimer’s Disease. J B & Bio Engine; 2021. [DOI: 10.47485/2693-2504.1050] [Reference Citation Analysis]
371 Lalli G, Schott JM, Hardy J, De Strooper B. Aducanumab: a new phase in therapeutic development for Alzheimer's disease? EMBO Mol Med 2021;13:e14781. [PMID: 34338436 DOI: 10.15252/emmm.202114781] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 25.0] [Reference Citation Analysis]
372 Dumurgier J, Sabia S. Life expectancy in dementia subtypes: exploring a leading cause of mortality. The Lancet Healthy Longevity 2021;2:e449-e450. [DOI: 10.1016/s2666-7568(21)00166-5] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
373 Mishra S, Knupp A, Szabo MP, Williams CA, Kinoshita C, Hailey DW, Wang Y, Young JE. The Alzheimer’s gene SORL1 is a regulator of endosomal traffic and recycling in human neurons.. [DOI: 10.1101/2021.07.26.453861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
374 Policarpo R, Sierksma A, De Strooper B, d'Ydewalle C. From Junk to Function: LncRNAs in CNS Health and Disease. Front Mol Neurosci 2021;14:714768. [PMID: 34349622 DOI: 10.3389/fnmol.2021.714768] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
375 Andersen OM, Bøgh N, Landau AM, Pløen GG, Jensen AMG, Monti G, Ulhøi BP, Nyengaard JR, Jacobsen KR, Jørgensen MM, Holm IE, Kristensen ML, Hansen ESS, Teunissen CE, Breidenbach L, Droescher M, Liu Y, Pedersen HS, Callesen H, Luo Y, Bolund L, Brooks DJ, Laustsen C, Small SA, Mikkelsen LF, Sørensen CB. In vivo evidence that SORL1, encoding the endosomal recycling receptor SORLA, can function as a causal gene in Alzheimer’s Disease.. [DOI: 10.1101/2021.07.13.452149] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
376 Ossenkoppele R, Reimand J, Smith R, Leuzy A, Strandberg O, Palmqvist S, Stomrud E, Zetterberg H, Scheltens P, Dage JL, Bouwman F, Blennow K, Mattsson-Carlgren N, Janelidze S, Hansson O; Alzheimer's Disease Neuroimaging Initiative. Tau PET correlates with different Alzheimer's disease-related features compared to CSF and plasma p-tau biomarkers. EMBO Mol Med 2021;13:e14398. [PMID: 34254442 DOI: 10.15252/emmm.202114398] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 18.0] [Reference Citation Analysis]
377 Liu J, Hou Z, Wu J, Liu K, Li D, Gao T, Liu W, An B, Sun Y, Mo F, Wang L, Wang Y, Hao J, Hu B. Infusion of hESC derived Immunity-and-matrix regulatory cells improves cognitive ability in early-stage AD mice. Cell Prolif 2021;54:e13085. [PMID: 34232542 DOI: 10.1111/cpr.13085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
378 Mazej T, Knez D, Meden A, Gobec S, Sova M. 4-Phenethyl-1-Propargylpiperidine-Derived Dual Inhibitors of Butyrylcholinesterase and Monoamine Oxidase B. Molecules 2021;26:4118. [PMID: 34299393 DOI: 10.3390/molecules26144118] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
379 Schemmert S, Camargo LC, Honold D, Gering I, Kutzsche J, Willuweit A, Willbold D. In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-d-Enantiomeric Peptide Developed for the Treatment of Alzheimer's Disease. Int J Mol Sci 2021;22:6553. [PMID: 34207233 DOI: 10.3390/ijms22126553] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
380 Li T, Wei Y, Qu M, Mou L, Miao J, Xi M, Liu Y, He R. Formaldehyde and De/Methylation in Age-Related Cognitive Impairment. Genes (Basel) 2021;12:913. [PMID: 34199279 DOI: 10.3390/genes12060913] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
381 Dominguez LJ, Di Bella G, Veronese N, Barbagallo M. Impact of Mediterranean Diet on Chronic Non-Communicable Diseases and Longevity. Nutrients 2021;13:2028. [PMID: 34204683 DOI: 10.3390/nu13062028] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 25.0] [Reference Citation Analysis]
382 van Gils AM, Visser LN, Hendriksen HM, Georges J, Muller M, Bouwman FH, van der Flier WM, Rhodius-meester HF. Assessing the Views of Professionals, Patients, and Care Partners Concerning the Use of Computer Tools in Memory Clinics: International Survey Study (Preprint).. [DOI: 10.2196/preprints.31053] [Reference Citation Analysis]
383 Gascon S, Jann J, Langlois-Blais C, Plourde M, Lavoie C, Faucheux N. Peptides Derived from Growth Factors to Treat Alzheimer's Disease. Int J Mol Sci 2021;22:6071. [PMID: 34199883 DOI: 10.3390/ijms22116071] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
384 Lin Y, Jin J, Lv R, Luo Y, Dai W, Li W, Tang Y, Wang Y, Ye X, Lin WJ. Repetitive transcranial magnetic stimulation increases the brain's drainage efficiency in a mouse model of Alzheimer's disease. Acta Neuropathol Commun 2021;9:102. [PMID: 34078467 DOI: 10.1186/s40478-021-01198-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
385 Candelise N, Scaricamazza S, Salvatori I, Ferri A, Valle C, Manganelli V, Garofalo T, Sorice M, Misasi R. Protein Aggregation Landscape in Neurodegenerative Diseases: Clinical Relevance and Future Applications. Int J Mol Sci 2021;22:6016. [PMID: 34199513 DOI: 10.3390/ijms22116016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
386 Wu S, Liu X, Jiang R, Yan X, Ling Z. Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer's Disease. Front Aging Neurosci 2021;13:650047. [PMID: 34122039 DOI: 10.3389/fnagi.2021.650047] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 28.0] [Reference Citation Analysis]
387 Cummings J, Bauzon J, Lee G. Who funds Alzheimer's disease drug development? Alzheimers Dement (N Y) 2021;7:e12185. [PMID: 34095442 DOI: 10.1002/trc2.12185] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
388 Hong Y, Choi YH, Han YE, Oh SJ, Lee A, Lee B, Magnan R, Ryu SY, Choi CW, Kim MS. Central Administration of Ampelopsin A Isolated from Vitis vinifera Ameliorates Cognitive and Memory Function in a Scopolamine-Induced Dementia Model. Antioxidants (Basel) 2021;10:835. [PMID: 34073796 DOI: 10.3390/antiox10060835] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
389 Kareem RT, Abedinifar F, Mahmood EA, Ebadi AG, Rajabi F, Vessally E. The recent development of donepezil structure-based hybrids as potential multifunctional anti-Alzheimer's agents: highlights from 2010 to 2020. RSC Adv 2021;11:30781-30797. [DOI: 10.1039/d1ra03718h] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
390 Jeong G. Recently Progressed Postbiotics as Nutraceuticals. Food Suppl Biomater Health 2021;1. [DOI: 10.52361/fsbh.2021.1.e33] [Reference Citation Analysis]